<!DOCTYPE article
 PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2 20190208//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="preprint"><?all-math-mml yes?><?use-mml?><?origin ukpmcpa?><front><journal-meta><journal-id journal-id-type="nlm-ta">bioRxiv</journal-id><journal-title-group><journal-title>bioRxiv : the preprint server for biology</journal-title></journal-title-group><issn pub-type="epub">2692-8205</issn></journal-meta><article-meta><article-id pub-id-type="manuscript">EMS199838</article-id><article-id pub-id-type="doi">10.1101/2024.11.01.621514</article-id><article-id pub-id-type="archive">PPR934054</article-id><article-version-alternatives><article-version article-version-type="status">preprint</article-version><article-version article-version-type="number">1</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>The mechanism of checkpoint-dependent DNA replication fork stabilization in human cells</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Bertolin</surname><given-names>Agostina P.</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Canal</surname><given-names>Berta</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Yekezare</surname><given-names>Mona</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Zeng</surname><given-names>Jingkun</given-names></name><xref ref-type="aff" rid="A1">1</xref></contrib><contrib contrib-type="author"><name><surname>Instrell</surname><given-names>Rachael</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Howell</surname><given-names>Michael</given-names></name><xref ref-type="aff" rid="A2">2</xref></contrib><contrib contrib-type="author"><name><surname>Diffley</surname><given-names>John F.X.</given-names></name><xref ref-type="aff" rid="A1">1</xref><xref ref-type="fn" rid="FN1">4</xref><xref ref-type="corresp" rid="CR1">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Chromosome Replication Laboratory, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tnbqb63</institution-id><institution>The Francis Crick Institute</institution></institution-wrap>, <city>London</city>, <country country="GB">UK</country></aff><aff id="A2"><label>2</label>High Throughput Screening Laboratory, <institution-wrap><institution-id institution-id-type="ror">https://ror.org/04tnbqb63</institution-id><institution>The Francis Crick Institute</institution></institution-wrap>; <city>London</city>, <postal-code>NW1 1AT</postal-code>, <country country="GB">UK</country></aff><author-notes><corresp id="CR1"><label>*</label>Correspondence: <email>john.diffley@crick.ac.uk</email> Tel: +44 (0) 203 796 1833</corresp><fn id="FN1"><label>4</label><p id="P1">Lead contact</p></fn></author-notes><pub-date pub-type="nihms-submitted"><day>04</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="preprint"><day>03</day><month>11</month><year>2024</year></pub-date><permissions><ali:free_to_read/><license><ali:license_ref>https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">CC BY-NC-ND 4.0 International license</ext-link>.</license-p></license></permissions><abstract><title>Summary</title><p id="P2">The DNA damage checkpoint is crucial for maintaining genome stability after genotoxic stress; without it, excess DNA replication origins are activated, stalled DNA replication forks cannot restart normally, high levels of DNA damage and single-stranded DNA (ssDNA) accumulate and cells cannot complete S phase. Preventing excess origin firing suppresses all these effects. Here we show that when replication is not restrained by a functional checkpoint, excess DNA synthesis sequesters the processivity factor PCNA and its loader RFC, preventing normal fork restart. Nascent DNA ends unprotected by RFC/PCNA are attacked by the Helicase-Like Transcription Factor (HLTF), causing irreversible replication fork collapse and hyperaccumulation of single-stranded DNA. This explains how the checkpoint stabilizes stalled replication forks and has implications for how origin firing is normally coordinated with fork progression. Loss of HLTF suppresses fork collapse and cell lethality in checkpoint-deficient cells, which has implications for how resistance to anti-checkpoint therapies may arise.</p></abstract><kwd-group><kwd>DNA replication</kwd><kwd>PCNA</kwd><kwd>RFC</kwd><kwd>Okazaki fragments</kwd><kwd>Polymerase α</kwd><kwd>DNA damage checkpoint</kwd><kwd>replication fork collapse</kwd><kwd>replication fork stabilization</kwd><kwd>RPA exhaustion</kwd><kwd>HLTF</kwd></kwd-group></article-meta></front><body><sec id="S1" sec-type="intro"><title>Introduction</title><p id="P3">DNA replication fork stalling in response to nucleotide depletion, inhibition of DNA polymerases or DNA damage activates the checkpoint protein kinases ATR and its downstream effector, Chk1<sup><xref ref-type="bibr" rid="R1">1</xref>–<xref ref-type="bibr" rid="R3">3</xref></sup>. In budding yeast, mice, and humans, these damage checkpoint kinases are essential for cell viability<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R4">4</xref>–<xref ref-type="bibr" rid="R12">12</xref></sup> and checkpoint defects in humans are associated with inherited developmental diseases, premature ageing, and predisposition to various types of cancer<sup><xref ref-type="bibr" rid="R13">13</xref>–<xref ref-type="bibr" rid="R18">18</xref></sup>. These kinases coordinate a wide range of cellular responses to promote genome stability and survival<sup><xref ref-type="bibr" rid="R19">19</xref></sup>, including regulation of damage-dependent transcription, DNA repair, and cell cycle arrest; however, the DNA replication-associated functions of the checkpoint appear to be especially important<sup><xref ref-type="bibr" rid="R20">20</xref>–<xref ref-type="bibr" rid="R22">22</xref></sup>. The checkpoint inhibits replication origin firing in yeast and humans; in yeast by inhibiting two replication origin firing factors, Sld3 and Dbf4<sup><xref ref-type="bibr" rid="R23">23</xref>,<xref ref-type="bibr" rid="R24">24</xref></sup> and in humans by targeting Cdc25A, the Cdk2 phosphatase and activator, for ubiquitin-mediated proteolysis<sup><xref ref-type="bibr" rid="R25">25</xref>–<xref ref-type="bibr" rid="R27">27</xref></sup>. The checkpoint also protects stalled replication forks in yeast and humans from undergoing catastrophic changes often referred to as ‘fork collapse’<sup><xref ref-type="bibr" rid="R28">28</xref></sup>. Replisomes stall irreversibly and can no longer resume replication, even if the checkpoint is restored<sup><xref ref-type="bibr" rid="R29">29</xref>,<xref ref-type="bibr" rid="R30">30</xref></sup>, and normal DNA replication fork structures are converted into structures associated with recombination<sup><xref ref-type="bibr" rid="R30">30</xref></sup>, despite the fact that CMG helicase and associated factors remains associated with DNA<sup><xref ref-type="bibr" rid="R31">31</xref></sup>. How checkpoints stabilize replication forks and the mechanistic basis for irreversible fork arrest are currently poorly understood. Nucleases including Exo1<sup><xref ref-type="bibr" rid="R32">32</xref>–<xref ref-type="bibr" rid="R34">34</xref></sup>, MRX<sup><xref ref-type="bibr" rid="R35">35</xref></sup> and the proofreading exonuclease of DNA polymerase ε<sup><xref ref-type="bibr" rid="R36">36</xref></sup> have all been implicated in this phenomenon in yeast. Evidence from human cells indicates that deregulation of origin firing in the absence of a functional checkpoint drives fork collapse<sup><xref ref-type="bibr" rid="R28">28</xref></sup> and that accumulation of ssDNA during this process depletes the soluble pool of the ssDNA binding protein RPA, which causes DNA damage<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. In this manuscript we have re-examined events occurring at stalled replication forks in the absence of a functional checkpoint in human cells and we provide evidence that depletion of Replication Factor C (RFC), the PCNA sliding clamp loader, by excess Okazaki fragments that is the initial driver of fork collapse, and that the Snf2-family DNA translocase HLTF executes the irreversible fork collapse.</p></sec><sec id="S2" sec-type="results"><title>Results</title><sec id="S3"><title>Checkpoint inhibition after replication fork stalling induces S phase catastrophe</title><p id="P4">Consistent with previous work showing that loss of ATR or Chk1 causes a diverse array of pathological phenotypes<sup><xref ref-type="bibr" rid="R1">1</xref>,<xref ref-type="bibr" rid="R11">11</xref>,<xref ref-type="bibr" rid="R17">17</xref>,<xref ref-type="bibr" rid="R37">37</xref>–<xref ref-type="bibr" rid="R41">41</xref></sup>, treatment of U2OS cells with ATR or Chk1 inhibitors (ATRi, Chk1i) caused cell lethality (<xref ref-type="supplementary-material" rid="SD1">Figures S1A and S1B</xref>) which was exacerbated by variety of genotoxic agents (<xref ref-type="fig" rid="F1">Figures 1A</xref> and <xref ref-type="supplementary-material" rid="SD1">S1C-S1F</xref>), including the DNA polymerase α, δ, and ε inhibitor aphidicolin (aph), which we use extensively in this manuscript. Addition of Chk1i during the last 4h of a 24h aphidicolin treatment increased DNA damage markers, chromatin-bound Rad51, increased ssDNA derived from both parental and nascent DNA and caused RPA exhaustion as evidenced by cessation of RPA accumulation on chromatin followed by accumulation of γH2AX (<xref ref-type="supplementary-material" rid="SD1">Figures S1G-S1K</xref>) consistent with previous work<sup><xref ref-type="bibr" rid="R38">38</xref>–<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R42">42</xref></sup>. Cells released from this treatment regime (aph/Chk1i, <xref ref-type="supplementary-material" rid="SD1">Figure S1L</xref>) were largely unable to complete S phase and enter mitosis, in contrast to cells released from aph-only, and the few cells that reached mitosis exhibited high levels of nuclear aberration (<xref ref-type="fig" rid="F1">Figures 1B, 1C</xref> and <xref ref-type="supplementary-material" rid="SD1">S1M</xref>).</p><p id="P5">Chk1 inhibition also had a profound effect on DNA replication fork restart (<xref ref-type="fig" rid="F1">Figures 1D-1F</xref>), consistent with previous work<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R43">43</xref>–<xref ref-type="bibr" rid="R45">45</xref></sup>. Cells were pulsed with CldU (green) for 20min, CldU was washed out, and aphidicolin and IdU (red), with or without checkpoint inhibitors, were added. After 4 hours, aphidicolin and IdU were washed out and IdU alone was added back (<xref ref-type="fig" rid="F1">Figure 1D</xref>). Replication forks from cells released from aph-only treatment immediately began to synthesise DNA after aph removal at rates very similar to unperturbed forks (<xref ref-type="fig" rid="F1">Figures 1D and 1E</xref>). Replication forks also resumed synthesis after aph/Chk1i treatment, however, fork rate was roughly 5 times slower (<xref ref-type="fig" rid="F1">Figures 1D and 1E</xref>). As expected<sup><xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R46">46</xref>–<xref ref-type="bibr" rid="R48">48</xref></sup>, transient checkpoint inhibition led to a significant increase in new origin firing measured as tracks labelled only in red (<xref ref-type="supplementary-material" rid="SD1">Figure S1N</xref>). These red-only tracks were much shorter after Chk1i (<xref ref-type="fig" rid="F1">Figure 1F</xref>) consistent with the idea that replication forks are affected by Chk1i regardless of whether they were established before or after checkpoint inhibitor addition. We did not detect nascent strand degradation<sup><xref ref-type="bibr" rid="R49">49</xref></sup> in either aph- or aph/Chk1i-treated cells (<xref ref-type="supplementary-material" rid="SD1">Figure S1O</xref>) indicating that the reduction in apparent extension rates observed after fork stalling in checkpoint deficient cells is a consequence of reduced replication fork elongation rate, not increased degradation rate, consistent with previous work<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R50">50</xref></sup>.</p><p id="P6">Fork rate when assessed by DNA fiber spreading was not affected when the Polα inhibitor, ST-1926<sup><xref ref-type="bibr" rid="R51">51</xref>,<xref ref-type="bibr" rid="R52">52</xref></sup>, was added during the restart of replication forks in aph-only cells; however, ST-1926 almost completely inhibited fork extension in aph/Chk1i-treated cells (<xref ref-type="fig" rid="F1">Figures 1G and 1H</xref>). Similar results were obtained with a second Polα inhibitor, CD-437<sup><xref ref-type="bibr" rid="R53">53</xref></sup> (<xref ref-type="supplementary-material" rid="SD1">Figure S1P</xref>). Although DNA fiber spreading cannot distinguish leading from lagging strands<sup><xref ref-type="bibr" rid="R54">54</xref></sup>, the synthesis of many kilobases of DNA after aph alone in the presence of the Polα inhibitor is most consistent with efficient resumption of leading strand replication, probably in the absence of lagging strand synthesis; the near complete inhibition of all synthesis after aphidicolin and Chk1i treatment can only be interpreted as loss of both leading and lagging strand synthesis. Therefore, the slow DNA synthesis during replication fork restart in checkpoint deficient cells is dependent upon Polα whilst the rapid synthesis seen in active forks after release from aph-only does not require Polα and is more consistent with resumption of processive leading strand DNA synthesis by Polδ and/or Polε.</p></sec><sec id="S4"><title>Order of effects following checkpoint inhibition</title><p id="P7">We next determined the order that the myriad phenotypes first appeared after checkpoint inhibition. We exposed aph-treated cells to increasing durations of Chk1 inhibitor, from 10 min to 5 hours (<xref ref-type="supplementary-material" rid="SD1">Figure S1Q</xref>). DNA damage markers were almost undetectable until 45 min after checkpoint inhibitor addition (<xref ref-type="fig" rid="F2">Figure 2A</xref>) while RPA exhaustion, defined as the point where γH2AX levels continue to rise without commensurate increase in chromatin-bound RPA, was first seen after 60 min of treatment and continued to accumulate over the next 4 hours (<xref ref-type="fig" rid="F2">Figure 2B</xref>). A clear increase in origin firing could be detected even at the earliest time points (10-20 min) after checkpoint inhibitor addition when compared to aphidicolin alone (<xref ref-type="fig" rid="F2">Figures 2C, 2D</xref> and <xref ref-type="supplementary-material" rid="SD1">S1R</xref>) consistent with previous work<sup><xref ref-type="bibr" rid="R38">38</xref></sup>. Defective replication fork restart was also observed early, after 20 min of Chk1i treatment (<xref ref-type="fig" rid="F2">Figure 2E</xref>). These results show that new origin firing and, importantly, fork defects occur well before the onset of detectable DNA damage or depletion of chromatin-bound RPA arguing that DNA damage generation or RPA exhaustion are likely to be downstream of new origin firing and/or fork defects following checkpoint inhibition.</p></sec><sec id="S5"><title>Excess origin firing depletes chromatin-bound PCNA and causes replication fork defects</title><p id="P8">New origin firing and fork restart defects started at similar times after Chk1i treatment. Inhibition of excess origin firing using either Cdc7 or Cdk2 inhibitors suppressed DNA damage markers, RPA exhaustion and the defect in replication fork restart associated with Chk1i (<xref ref-type="fig" rid="F3">Figures 3A-3C</xref> and <xref ref-type="supplementary-material" rid="SD1">S2A</xref>), in agreement with previous work<sup><xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R44">44</xref></sup> and also rescued mitotic entry and viability (<xref ref-type="supplementary-material" rid="SD1">Figures S2B</xref> and <xref ref-type="fig" rid="F3">3D</xref>). This suggests that the generation of an excessive number of replication forks depletes some essential replication factor. It has previously been proposed that this limiting factor is RPA: treatment with hydroxyurea and checkpoint inhibitors generates sufficient ssDNA to exhaust the soluble pool of RPA, resulting in DNA damage, fork breakage and ultimately fork collapse<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. However, our results indicate that fork defects precede RPA exhaustion. RPA overexpression (<xref ref-type="supplementary-material" rid="SD1">Figure S2C</xref>) rescued some of the DNA damage seen at 120 min and later (<xref ref-type="supplementary-material" rid="SD1">Figure S2D</xref>) consistent with previous work<sup><xref ref-type="bibr" rid="R37">37</xref></sup>. However, it did not rescue the DNA damage observed at earlier time points. Moreover, RPA overexpression did not rescue the Chk1i-induced fork restart defects at any time point (<xref ref-type="supplementary-material" rid="SD1">Figure S2F</xref>). Consistent with this, chromatin-bound RPA levels are relatively low in the first 30 min when restart defects first occur, but continue to rise steadily over time, and do not plateau until 4 hours of checkpoint inhibition (<xref ref-type="fig" rid="F3">Figure 3E</xref>). Thus, RPA is unlikely to be the replication factor limiting for fork restart seen from early time points, though its depletion does contribute to DNA damage at later time points.</p><p id="P9">In sharp contrast to RPA, however, we found that the amount of PCNA bound to chromatin reached a maximum level within 30 min of checkpoint inhibition (<xref ref-type="fig" rid="F3">Figure 3F</xref>) despite the fact that the number of new forks continued to rise over 2 hours (<xref ref-type="fig" rid="F2">Figures 2D</xref> and <xref ref-type="supplementary-material" rid="SD1">S1R</xref>). We therefore considered this decrease in the amount of PCNA per fork could be responsible for the replication fork restart defect, analogous to results in the accompanying manuscript. Consistent with this and with previous work<sup><xref ref-type="bibr" rid="R55">55</xref></sup>, transient reduction of either PCNA or the PCNA clamp loader RFC1 (<xref ref-type="supplementary-material" rid="SD1">Figure S2G</xref>) caused DNA damage and affected replication restart, even in the absence of excess origin firing and regardless of checkpoint status (compare <xref ref-type="fig" rid="F3">Figures 3G with 3H</xref> and with <xref ref-type="supplementary-material" rid="SD1">S2H</xref>)<sup><xref ref-type="bibr" rid="R55">55</xref></sup>, suggesting that reduction of chromatin-bound PCNA levels prevents normal fork restart. Transient overexpression of PCNA led to a significant increase of DNA damage markers in aphidicolin conditions alone (<xref ref-type="supplementary-material" rid="SD1">Figures S2I and S2J</xref>), suggesting non-specific effects. We therefore turned to a different approach, depletion of the main PCNA unloader, ATAD5/Elg1<sup><xref ref-type="bibr" rid="R56">56</xref>,<xref ref-type="bibr" rid="R57">57</xref></sup>. ATAD5 was among the top 10 hits in a whole-genome CRISPR-Cas9 dropout screen in RPE1 cells for genes whose loss conferred resistance to the ATR inhibitor AZD6738<sup><xref ref-type="bibr" rid="R58">58</xref></sup>, ranking higher than known sensitivity determinants such as Cdc25A and Cdc25B<sup><xref ref-type="bibr" rid="R59">59</xref></sup>. ATAD5 was also identified as a top hit in a similar whole-genome CRISPR-Cas9 dropout screen for AZD6738 in mouse embryonic stem cells<sup><xref ref-type="bibr" rid="R60">60</xref></sup>. ATAD5 depletion led to a significant increase in chromatin-bound PCNA (<xref ref-type="fig" rid="F3">Figure 3I</xref>). This almost completely suppressed the Chk1i-induced fork restart defects and accumulation of DNA damage markers (<xref ref-type="fig" rid="F3">Figures 3J and 3K</xref>). Co-depletion of PCNA, but not Rad18, with ATAD5 prevented suppression of DNA damage (<xref ref-type="supplementary-material" rid="SD1">Figures S2K and S2L</xref>), arguing that suppression is due to the increased chromatin-bound PCNA and not to an increase in K164 mono-ubiquitylation of PCNA. Importantly, ATAD5 depletion did not prevent excess origin firing (<xref ref-type="fig" rid="F3">Figure 3L</xref>) consistent with previous work<sup><xref ref-type="bibr" rid="R61">61</xref></sup>.</p><p id="P10">PCNA is an abundant protein, and, consistent with this, even after 120 min of Chk1 inhibitor exposure, PCNA, as well as RPA, were detected in soluble as well as chromatin fractions (<xref ref-type="fig" rid="F3">Figure 3M</xref>). Similarly, RFC3, one of the core RFC subunits present in all RFC complexes, was also detected in both fractions. By contrast, RFC1, which is roughly 10-fold less abundant than the core RFC subunits and ~20 fold less abundant than PCNA<sup><xref ref-type="bibr" rid="R62">62</xref></sup>, was detectable on chromatin but not in the soluble fraction, even at the earliest times (<xref ref-type="fig" rid="F3">Figure 3M</xref>). This argues that, during excess of origin firing, RFC1-5, rather than PCNA is depleted.</p></sec><sec id="S6"><title>HLTF is responsible for the defects caused by RFC/PCNA-depleted forks in the absence of the checkpoint</title><p id="P11">Our results thus far show that excess origin firing drives RFC/PCNA depletion, which prevents normal replication restart. They do not, however, explain where the DNA damage and excessive ssDNA come from or why the fork arrest is irreversible. We developed an RNA interference-based genome-wide screen in human cells transiently treated with aph and Chk1 inhibitors where we monitored γH2AX levels as a marker for DNA damage and the mitotic phosphorylation of H3 (pH3-S10) as an indicator of S/G2 phase completion (for further details see <xref ref-type="supplementary-material" rid="SD1">Figure S3</xref> and <xref ref-type="supplementary-material" rid="SD1">Tables S1 and S2</xref>). When focusing on the siRNAs that increased γH2AX levels, we found that out of the ~21,000 genes tested, RFC2 depletion emerged as the highest-scoring gene, RFC1 depletion ranked among the top 20, and all RFC subunits increased γH2AX levels (<xref ref-type="supplementary-material" rid="SD1">Figure S3E</xref>), further supporting the idea that RFC1-5 is the limiting factor preventing normal fork restart.</p><p id="P12">Next, we identified genes whose knockdown reduced DNA damage and promoted mitotic entry after Chk1i removal, indicating S-phase completion through fork resumption. After secondary screens and siRNA deconvolution, one of the strongest such suppressors was Helicase-Like Transcription Factor (HLTF, also known as SMARCA3) (<xref ref-type="supplementary-material" rid="SD1">Figure S3F</xref> and <xref ref-type="supplementary-material" rid="SD1">Table S2</xref>). HLTF is a fork-associated protein, ubiquitin ligase and SNF2-family DNA translocase implicated in several DNA repair/tolerance pathways<sup><xref ref-type="bibr" rid="R63">63</xref>–<xref ref-type="bibr" rid="R68">68</xref></sup>. Moreover, HLTF inactivation reduces DNA damage and slightly increases resistance to genotoxic agents and ATR inhibitors<sup><xref ref-type="bibr" rid="R64">64</xref></sup>. We found that both HLTF siRNA depletion and CRISPR/Cas9 gene knockout (HLTF-KO) strongly reduced phosphorylation of all DDR markers analysed in aph-treated cells after Chk1 or ATR inhibition (<xref ref-type="fig" rid="F4">Figures 4A</xref>, <xref ref-type="supplementary-material" rid="SD1">S4A and S4B</xref>). Complementation of HLTF-KO cells with full-length HLTF cDNA (<xref ref-type="supplementary-material" rid="SD1">Figure S4C</xref>) restored the elevated DNA damage induced by checkpoint inhibition (<xref ref-type="supplementary-material" rid="SD1">Figure S4D</xref>). High levels of parental and nascent ssDNA, Rad51 foci and DSBs were almost completely suppressed in aph/Chk1i cells in the absence of HLTF (<xref ref-type="fig" rid="F4">Figures 4B</xref> and <xref ref-type="supplementary-material" rid="SD1">S4E-S4G</xref>). This reduction in S phase-related DNA damage in HLTF deficient cells was accompanied by enhanced levels of mitotic entry and a strong reduction in Chk1i-induced genomic instability (<xref ref-type="fig" rid="F4">Figures 4C</xref> and <xref ref-type="supplementary-material" rid="SD1">S4H</xref>) consistent with these cells being able to resume replication and complete S phase (<xref ref-type="supplementary-material" rid="SD1">Figure S4I</xref>). HLTF depletion and gene knockout suppressed the replication restart defects in ATR- or Chk1-inhibited cells from replication forks established either before or after Chk1 inhibition (<xref ref-type="fig" rid="F4">Figures 4D, 4E</xref>, <xref ref-type="supplementary-material" rid="SD1">S4J and S4K</xref>). Notably, the suppression of restart defects seen in HLTF-deficient cells occurred despite the excess origin firing and depletion of chromatin-bound PCNA (<xref ref-type="supplementary-material" rid="SD1">Figures S4L-S4N</xref>). Consistent with this, HLTF ranked among the top 5 hits in CRISPR dropout screens for resistance to ATR and Chk1 inhibitors using a DNA damage sgRNA sub-library<sup><xref ref-type="bibr" rid="R69">69</xref></sup>. Moreover, it scored among the top hits in whole-genome CRISPR-Cas9 screens in MCF10<sup><xref ref-type="bibr" rid="R70">70</xref></sup> and RPE1<sup><xref ref-type="bibr" rid="R58">58</xref></sup> cells for resistance to the ATR inhibitor AZD6738.</p><p id="P13">To further investigate the drivers of fork collapse, we examined cellular processes involving HLTF. HLTF, along with the E2 ubiquitin-conjugating complex Mms2/Ubc13, polyubiquitylates PCNA in response to DNA damage to initiate error-free lesion bypass via template switching<sup><xref ref-type="bibr" rid="R66">66</xref>,<xref ref-type="bibr" rid="R71">71</xref>,<xref ref-type="bibr" rid="R72">72</xref></sup>. We generated MMS2 and Ubc13 CRISPR-KO cells, neither of which suppressed DNA damage in the absence of checkpoint activity (<xref ref-type="supplementary-material" rid="SD1">Figure S5A</xref>), suggesting PCNA polyubiquitination is not involved in fork collapse. SHPRH, like HLTF, is a human Rad5 ortholog with a RING domain and SWI/SNF-ATPase helicase but lacks the HIRAN domain<sup><xref ref-type="bibr" rid="R67">67</xref>,<xref ref-type="bibr" rid="R72">72</xref>,<xref ref-type="bibr" rid="R73">73</xref></sup>. We generated SHPRH KO cells, and they show levels of DNA damage marker phosphorylation similar to controls after checkpoint inhibition, suggesting no involvement in this process (<xref ref-type="supplementary-material" rid="SD1">Figure S5B</xref>). Genetic and biochemical studies suggest that replication fork reversal<sup><xref ref-type="bibr" rid="R74">74</xref></sup> is predominantly catalyzed by the SNF2-family DNA translocases HLTF<sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref></sup>, SMARCAL1<sup><xref ref-type="bibr" rid="R75">75</xref></sup> and ZRANB3<sup><xref ref-type="bibr" rid="R76">76</xref>,<xref ref-type="bibr" rid="R77">77</xref></sup> and SMARCAL1 has been shown to be required for the generation of nascent-strand ssDNA in human cells when ATR is inactivated<sup><xref ref-type="bibr" rid="R38">38</xref></sup>. So, we tested whether SMARCAL1 or ZRANB3 are required to promote fork collapse in the absence of a functional checkpoint. Individual and double CRISPR-KO U2OS cell lines of SMARCAL1 and ZRANB3 did not suppress Chk1 inhibition-induced phosphorylation of DNA damage markers (<xref ref-type="supplementary-material" rid="SD1">Figure S5C</xref>), generation of parental ssDNA or accumulation of RPA and Rad51 foci (<xref ref-type="supplementary-material" rid="SD1">Figure S5D</xref>). Moreover, epistasis experiments revealed that HLTF depletion suppressed Chk1 inhibition-induced DNA damage markers, regardless of ZRANB3 or SMARCAL1 status (<xref ref-type="supplementary-material" rid="SD1">Figure S5E</xref>). These findings suggest that SMARCAL1 and ZRANB3 are not involved in triggering checkpoint inhibition-induced fork collapse.</p><p id="P14">Our results suggest that depletion of RFC/PCNA by excess OkF synthesis from the excess origins generates a substrate for HLTF to act upon, leading to fork collapse. In line with this, ATAD5 and HLTF depletion alleviated the effects observed when PCNA and/or RFC1 are depleted without excess origin firing and regardless of checkpoint status (<xref ref-type="fig" rid="F5">Figures 5A-5C</xref>). This suggests that PCNA retention on chromatin can protect free 3’-ends from nuclease attack and that HLTF can cause fork restart defects even in the presence of a functional checkpoint. Consistent with this, overexpressing HLTF without fork stalling or checkpoint inhibition led to an increase in DNA damage markers (<xref ref-type="fig" rid="F5">Figure 5D</xref>). These results suggest that the checkpoint may protect replication forks from HLTF even in the absence of genotoxic stress. HLTF-deficient cells showed increased resistance to ATR and Chk1 inhibitors in the absence (<xref ref-type="fig" rid="F4">Figure 4F</xref> and <xref ref-type="supplementary-material" rid="SD1">S6F</xref>) and presence (<xref ref-type="fig" rid="F4">Figures 4G</xref> and <xref ref-type="supplementary-material" rid="SD1">S6</xref>) of a variety of genotoxic drugs (aph/HU/Cisplatin/Olaparib).</p></sec></sec><sec id="S7" sec-type="discussion"><title>Discussion</title><p id="P15">The work described here, together with accompanying manuscript showing the detailed molecular mechanism through biochemical reconstitution of DNA replication fork stalling and restart, provides a novel framework for understanding how the DNA damage checkpoint stabilizes stalled replication forks in human cells (<xref ref-type="fig" rid="F5">Figure 5E</xref>). When DNA replication origin firing is not restrained by the checkpoint after inhibition of DNA synthesis, excess Okazaki fragments (OkFs) are initiated; these OkFs sequester PCNA and the canonical Rfc1-containing RFC complex, which becomes specifically depleted. As incomplete OkFs accumulate (OkF synthesis cannot complete because of DNA polymerase inhibition, see accompanying manuscript), the depletion of RFC/PCNA exposes 3’ DNA ends and it is the action of HLTF on these exposed ends that causes fork collapse (<xref ref-type="fig" rid="F5">Figures 5E</xref>). HLTF localises to replication forks even in the absence of genotoxic stress<sup><xref ref-type="bibr" rid="R63">63</xref></sup> and promotes fork reversal <italic>in vivo</italic> and <italic>in vitro</italic> via a HIRAN domain that binds to 3’ DNA ends<sup><xref ref-type="bibr" rid="R63">63</xref>,<xref ref-type="bibr" rid="R64">64</xref>,<xref ref-type="bibr" rid="R78">78</xref>,<xref ref-type="bibr" rid="R79">79</xref></sup>. We propose that the irreversible effect of HLTF on replication forks is the initiation of unwinding of the nascent leading strand<sup><xref ref-type="bibr" rid="R80">80</xref></sup>, which exposes ssDNA from both the nascent and parental strands (<xref ref-type="supplementary-material" rid="SD1">Figure S4E</xref>) and depletes RPA (<xref ref-type="fig" rid="F4">Figure 4B</xref>) consistent with previous work<sup><xref ref-type="bibr" rid="R37">37</xref>,<xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R40">40</xref>,<xref ref-type="bibr" rid="R42">42</xref></sup>. By eliminating the nascent leading strand, any continued unwinding by CMG after restart can only support lagging strand synthesis, which explains why all synthesis after aph/Chk1i treatment is slow and is sensitive to Polα inhibitors (<xref ref-type="fig" rid="F1">Figures 1G and 1H</xref> and <xref ref-type="supplementary-material" rid="SD1">S1P</xref>). Although PRIMPOL may be able to generate primers on the leading strand template<sup><xref ref-type="bibr" rid="R81">81</xref></sup>, these cannot be efficiently extended under conditions of RFC/PCNA depletion.</p><p id="P16">The work in this manuscript emphasises the critical role for checkpoint regulation of origin firing; we do not know whether checkpoint-dependent phosphorylation of Claspin (human orthologue of Mrc1), Mcm10 or other replisome components also contributes to inhibiting OkF synthesis by slowing forks in humans as it does in yeast<sup><xref ref-type="bibr" rid="R82">82</xref></sup> (see accompanying manuscript).</p><p id="P17">Our work also provides insights into the role of the checkpoint in coordinating replication during an unperturbed S phase. HLTF promotes cell lethality after checkpoint inhibition even <italic>without</italic> added replicative stress (<xref ref-type="fig" rid="F4">Figure 4F</xref>), HLTF is responsible for the DNA damage induced by partial PCNA or RFC knockdown even in the presence of a functional checkpoint (<xref ref-type="fig" rid="F5">Figures 5A-5C</xref>) and HLTF overexpression causes DNA damage even in the presence of a functional checkpoint (<xref ref-type="fig" rid="F5">Figure 5D</xref>). These results suggest that the balance between HLTF, RFC/PCNA/3’-ends and the DNA damage checkpoint is crucial even during an unperturbed S phase (<xref ref-type="fig" rid="F5">Figure 5F</xref>). We suggest that, upon entry into S phase, origin activation continues until the number of forks begins to deplete RFC. RFC depletion causes uncoupling of leading strand synthesis from CMG progression and prevents OkF completion and maturation, generating ssDNA on the leading and lagging strand templates which drive checkpoint activation. Excess origin activation also cause dNTP depletion<sup><xref ref-type="bibr" rid="R41">41</xref></sup>, which, as shown in the accompanying manuscript, can promote RFC/PCNA depletion and thus may also contribute to checkpoint activation. Checkpoint activation then inhibits new origin firing, preventing further RFC/PCNA depletion; as OkFs mature and replicons terminate, RFC and PCNA are released and recycled and as RFC depletion is relieved, the checkpoint signal is quenched, allowing new origins to fire. Thus, RFC/PCNA/3’-ends homeostasis, reinforced by dNTP depletion, ensures a constant level of origin firing throughout S phase (<xref ref-type="fig" rid="F5">Figure 5F</xref>). Consistent with this model, Chk1 is active throughout unperturbed S phase<sup><xref ref-type="bibr" rid="R83">83</xref></sup>, and inhibition of the checkpoint during unperturbed S phase leads rapidly to increased origin firing<sup><xref ref-type="bibr" rid="R38">38</xref>,<xref ref-type="bibr" rid="R43">43</xref>,<xref ref-type="bibr" rid="R44">44</xref>,<xref ref-type="bibr" rid="R48">48</xref>,<xref ref-type="bibr" rid="R84">84</xref></sup>, indicating that the checkpoint is constantly suppressing new origin firing. Conditions that limit origin activation should prevent RFC depletion and accelerate fork rate and consistent with this, previous work has shown that reducing origin firing by manipulating the levels of Cdc7, CDK, or Orc1 results in faster unperturbed fork rates, supporting this view<sup><xref ref-type="bibr" rid="R85">85</xref>,<xref ref-type="bibr" rid="R86">86</xref></sup>.</p><p id="P18">HLTF is frequently silenced by promoter hypermethylation in colon, gastric, oesophageal and other cancers<sup><xref ref-type="bibr" rid="R78">78</xref></sup> and HLTF knockout promotes malignant transformation in mice<sup><xref ref-type="bibr" rid="R87">87</xref></sup>. Additionally, tumour cells express high levels of PCNA<sup><xref ref-type="bibr" rid="R88">88</xref></sup> and RFC<sup><xref ref-type="bibr" rid="R89">89</xref>,<xref ref-type="bibr" rid="R90">90</xref></sup> presumably to accommodate their high degree of uncontrolled replication and to overcome RFC/PCNA depletion. This is also consistent with <italic>Atad5</italic> heterozygous mice being cancer prone<sup><xref ref-type="bibr" rid="R91">91</xref>,<xref ref-type="bibr" rid="R92">92</xref></sup> and with <italic>Atad5</italic> being identified as a genetic risk locus in genome-wide association studies for breast cancer<sup><xref ref-type="bibr" rid="R93">93</xref></sup> and serous ovarian cancer<sup><xref ref-type="bibr" rid="R94">94</xref></sup>. This suggests HLTF functions as a tumour suppressor and that maintaining RFC/PCNA/3’-end homeostasis may serve as a tumour suppressive mechanism. We hypothesise that loss of HLTF may make some cancer cells – perhaps those with compromised DNA checkpoints or with dysregulated origin firing–resistant to chemotherapies. This may be especially important as a route for the emergence of drug resistance in cancers treated with DNA checkpoint inhibitors.</p></sec><sec id="S8" sec-type="materials | methods"><title>Materials and Methods</title><sec id="S9"><title>Cell Culture</title><p id="P19">The following cell lines used in this study (U2OS, hTERT-RPE1, HeLa Kyoto) were originally obtained from ATCC and were cultured in DMEM (Sigma). eHAP cells obtained from Horizon Discovery were cultured in IMDM medium (Life Technologies). Cultures were supplemented with 10% FBS (Invitrogen), L-glutamine (GlutaMAX, ThermoFisher) and penicillin and streptomycin (Gibco). All cells were grown at 37 °C in 5% CO2. The cell lines used in our study were authenticated by STR profiling in the Crick Cell Service Crick facility. All cells are routinely tested to be mycoplasma free.</p></sec><sec id="S10"><title>RNA Interference, drugs, and small molecule inhibitors</title><p id="P20">Knockdown studies were performed using siRNA from Dharmacon. siRNAs were transfected at 5-50 nM final concentration depending on the experiment using Lipofectamine RNAiMAX (Invitrogen) and OptiMEM (Invitrogen). Experiments were completed 2 days after siRNA transfection. The following siRNAs were used: siRNA Control (siGENOME, non-targeting siRNA Pool #2, D-001206-14-20); siRNA HLTF-1 (ON-TARGETplus, SMARTpool, L-006448-00); siRNA HLTF-2 (siGENOME, D-006448-04); siRNA PCNA (ON-TARGETplus, SMARTpool, L-003289-00); siRNA RFC1 (ON-TARGETplus, SMARTpool, L-009290-00). The following used small molecule inhibitors/drugs were used: AZD7762 and MK-8776 (CHK1 inhibitors, 50-100 nM, Axon MedChem), VE-821 and VE-822 (ATR inhibitors, 500 nM, SelleckChem). Zeocin and blasticidin (4 μg/ml) were obtained from Life Technologies. Phalloidin (ThermoFisher). Aphidicolin (0.5-1 mg/ml), nocodazole (100 ng/ml), BrdU (20 μM) and cytochalasin B (4.5 μg/ml), PARPi (Olaparib), cisplatin, hydroxyurea and doxycycline were obtained from Sigma-Aldrich. Cdc7 inhibitor (XL-143, 5 to 10 μM, Axon), CDK2/1 inhibitor (roscovitine, 5 to 10 μM, Calbiochem), DNA-polymerase α inhibitors (CD437, Sigma-Aldrich and ST1926, MedChem).</p></sec><sec id="S11"><title>Cell lines</title><p id="P21"><italic>CRISPR-Cas9 Knock-out cell lines</italic>∸ For creation of HLTF knockout cells, the following gRNA sequences designed using Benchling software based on human HLTF Exon 2 sequence (NM_003071.3): 5’ CACCGTTGGACTACGCTATTACAC 3’ and 5’aaacGTGTAATAGCGTAGTCCAAC 3’. In all cases, U2OS or eHAP parental cells were transfected using Lipofectamine 3000 (Invitrogen) with pX459-sgRNA (gRNAs targeting unique sequences within each gene locus) and selected briefly with Puromycin for two days. Live single cells were sorted by flow cytometry, plated into 96-well plates, and allow to grow for 2 weeks. Individual clones were screened for the absence of HLTF protein expression by immunoblotting with the specific antibodies (ab17984, Abcam). <underline>HLTF over-expressing cell lines.</underline> Stable TetON-HLTF cell lines were constructed by random plasmid integration. Human coding sequences of HLTF were cloned using KpnI/NotI restriction enzymes into the pcDNA4/TO vector (Invitrogen) using the following primers:</p><p id="P22">Forward (KpnI) 5’GG<underline>GGTACC</underline>ATGTCCTGGATGTTCAAGAGGG 3’</p><p id="P23">Reverse (NotI) 5’ATAGTTTA<underline>GCGGCCGC</underline>TTATAAGTCAATTAATGTTC 3’</p><p id="P24">T-REx-U2OS cells were obtained from Invitrogen. T-REx-HLTF-KO cells stably expressing the Tet repressor were constructed by transfecting HLTF-KO U2OS cells with the pcDNA6/TR plasmid (Invitrogen) and cells were selected in medium containing 5 μg/ml Blasticidin. Live single cells were sorted by flow cytometry, plated into 96-well plates, and allow to grow for 2 weeks. Individual clones were screened for the Tet repressor protein expression by immunoblotting with the specific antibodies (TET02, MoBiTec) and positive clones were selected. T-REx-wild type cells or T-REx-HLTF-KO cells were transfected with Lipofectamine 3000 (Invitrogen) using the pcDNA4/TO constructs carrying human HLTF sequence. Transformed cells were selected in 250 μg/ml Zeocin. Live single cells were sorted by flow cytometry, plated into 96-well plates, and allow to grow for 2 weeks. Individual clones were screened for Doxycycline dependent protein expression by immunoblotting with HLTF antibodies (ab17984, Abcam) and positive clones were selected.</p></sec><sec id="S12"><title>Flow cytometry and cell sorting</title><p id="P25">Multiplexed flow cytometry analysis using fluorescent cell barcoding, combined with EdU, antibody and DNA staining, was performed as previously described <sup><xref ref-type="bibr" rid="R94">94</xref></sup>. Up to 6 samples subjected to different treatments were barcoded in each experiment to allow unbiased subsequent antibody staining of the combined samples. For detection of EdU, cells pulsed with 10 mM EdU for the indicated times were harvested and stained with Click-iT chemistry using Click-iT EdU Alexa Fluor 647 Flow Cytometry Assay Kit (Thermo, C10424) according to the manufacturer’s instructions. To quantify the amount of proteins in the insoluble/chromatin fraction, cells were treated with cytoskeleton buffer (CSK) 0.25% Triton X-100 for 5 min on ice. For DNA content analysis, cells were treated with 100 mg/mL RNase A and stained with 1 mg/mL DAPI. Data were analysed using FlowJo software. Cell doublets were excluded for all analyses. See Antibodies for details.</p></sec><sec id="S13"><title>Antibodies</title><p id="P26">The antibodies used for western blotting were the following: HLTF (ab17984, Abcam); pH2AX-S139 (γH2AX, 1:2000, clone JBW301, Millipore), pChk1-S345 (1:3000, 2348L, Cell signalling); pKAP1 S824 (1:1000, A300-767A, Bethyl); pRPA2-S4S8 (1:7500, A300-245A, Bethyl); KU70 (1:3000, sc-5309, Santa Cruz); alpha-Tubulin (1:4000, Sigma, T5168); PCNA (1:1000, PC10, Santa Cruz); RFC3 (1:1000, ab182143, Abcam); RFC1 (1:1000, ab229229, Abcam); RFC1 (1:1000, sc-271656, Santa Cruz); H3 (1:1000, ab1791, Abcam). Blots were imaged using the LI-COR platform (LI-COR Biosciences) with anti-rabbit RDye 800CW and anti-mouse IRDye680RD secondary antibodies (both 1:10000). Images were analyzed and quantified using the Odyssey Infrared imaging system (LI-COR Biosciences).</p><p id="P27">The antibodies used for flow cytometry were the following: pH3-S10 (1:200, ab14955, Abcam); pH2AX-S139 (γH2AX, 1:250, clone JBW301, Millipore); PCNA (1:250, PC10, Santa Cruz); RPA32 (1:250, ab2175, Abcam); RPA70 (1:250, EPR3472, Abcam). For chromatin RPA exhaustion/depletion, pH2AX-S139 (γH2AX, 1:250, ab11174, Abcam) in combination with RPA32 (1:250, ab2175, Abcam). The antibodies used for immunofluorescence studies were the following: RPA (Ab-2 NA18, Calbiochem), RPA (9H8 ab2175, Abcam); Rad51 (H92, Santa Cruz); BrdU (Becton Dickinson).</p></sec><sec id="S14"><title>DNA fiber stretching assay</title><p id="P28">U2OS cells were pulse labelled with 25 μM CldU for 20 min, washed with PBS and subsequently pulse labelled with 250 μM IdU together with aphidicolin (1 mg/ml) with or without Chk1 inhibitor (AZD7662, 50nM) or ATR inhibitor (VE-821, 500 nM) for the indicated time (from 10 min to 4h). Cells were washed with warm PBS 3 times and immediately harvest or release in complete media with 250 μM IdU for the indicated time (20 to 120 min). Cells were then trypsinised and resuspended at a concentration of 4x10<sup>5</sup> cell/ml in cold PBS. 3 ul of cell suspension were spotted on clean glass slides, air-dried for 5 min and lysed with 8 ul of 0.5% SDS in 200 mM Tris-HCL, pH 7.4, 50 mM EDTA (2-5 min, RT). Slides were slightly tilted, allowing the drop to run down the slide, air-dried for 10 min and then fixed in fresh methanol/acetic acid (3:1) for 10 min at RT. Then, air dried ON at 4 °C. Samples were then denatured (2.5 M HCl for 75 min). Slides were blocked in 1% BSA/PBS + 0.1% Tween-20 for 30 min at RT and incubated with rat anti-BrdU monoclonal antibody (αCldU; AbD Serotec) and mouse anti-BrdU monoclonal antibody (αIdU; Becton Dickinson), both 1:500 for 1h at RT. Later, slides were incubated with anti-rat IgG Alexa Fluor 488 (Green, Molecular Probes) and anti-mouse and IgG AlexaFluor 555 (Red, Molecular Probes) both at 1:500 for 1.5h at RT. Slides were washed and mounted with Fluoroshield (Sigma). Images were acquired using a Zeiss Upright 710 confocal microscope with 60x or 43x oil immersion objective. Fiber length was measured using FIJI. The pixel size values were converted into micrometres (μm) using the scale bars created by the microscope and then converted to kilobases according to the conversion factor 1 μm = 2.59 kb. For IdU length measures, otherwise indicated, only bicolour fibers were counted (green-red). For new origin firing quantification, origins fired during the second pulse (IdU, red structures) were quantified as percentage of all structures containing red (green-red and red only). Between 200-700 total replication structures were scored in each sample. Experiments were performed in duplicate or in triplicate.</p></sec><sec id="S15"><title>Nuclear aberration analysis</title><p id="P29">Transfected cells were replated at low density. 24 hr after replating cytochalasin B (4.5 μg/ml Sigma) was added to the media and 40 hr later cells were washed 1 min with hypotonic buffer (KCl 0.0075 M) diluted 1/10 from stock solution in PBS 1X, twice with PBS 1X and fixed with PFA/sucrose 2% for 20 min. Phalloidin and DAPI staining were used to visualize the whole cell and its nuclei respectively.</p></sec><sec id="S16"><title>Survival Assay</title><p id="P30">For colony formation assays, cells were seeded in duplicates (6-cm dishes) per condition and allowed to adhere for a minimum of 6 h. Cells were then treated with indicated concentrations of Aph for 24 h, washed extensively and incubated in drug-free medium for 11 days. Plates were then washed once in PBS, left to dry, and stained with cell staining solution (0.5% w/v crystal violet, 25% v/v methanol). Finally, the plates were washed three times in deionized water. Colonies were counted manually and surviving fraction calculated as: colonies/(seeded colonies × plating efficiency). For cell viability assays, we used CellTiter-Glo Luminescent Cell Viability Assay (Promega) which measures total cellular ATP. 200 to 500 cells per well were seeded in white opaque 96-well plates. 24h later, cells were treated with the indicated concentrations of aph, checkpoint inhibitors, HU, PARP inhibitors for 6 days. Prior to measurement, 75μL of CellTiter-Glo reagent was added into each well and the contents were mixed for 30 min to induce cell lysis on an orbital shaker. Luminescence was measured using the bioluminescence plate reader Envision 2102 (Perkin Elmer).</p></sec><sec id="S17"><title>Immunofluorescence staining</title><p id="P31">Anti-BrdU. To detect single stranded DNA under non-denaturing conditions, U2OS cells were seeded 24 h prior to treatment on 12 mm coverslips in 12-well plates. For parental ssDNA, BrdU (10 μM) was added for a total of 48h (24h before aph treatment and 24h with aph treatment). For nascent ssDNA, BrdU (20 μM) was added to aph-treated cells 10 min before and during the 4h treatment with checkpoint inhibitors. Cells were permeabilised at 4°C for 10 min in PBS + 0.5% Triton X-100 followed by fixation at room temperature (RT) for 10 min in 4% paraformaldehyde (PFA). Cells were fixed again at −20°C with 100% methanol for 10 min, dried for 1 min, and then washed with PBS. Cells were then incubated at RT with blocking solution -PBS-T and 2% BSA-for 1h. Coverslips were then incubated with primary antibodies: mouse anti-BrdU (BD Biosciences; clone B44, 1:200 at 37°C for 1h. Coverslips were washed for 5 min in PBS-T and incubated at RT for 1h with secondary antibodies (1:500; Alexa Fluor 488). Coverslips were then washed with PBS-T and stained with DAPI (1 μg/mL) and mounted on microscope slides with Fluoroshield (Sigma). <bold>RPA and Rad51</bold>. U2OS cells were seeded on 12 mm coverslips in 12-well plates 24 h prior to treatment. Cells were treated with the indicated drugs. Coverslips were then incubated in cytoskeleton buffer (CSK) 0.5% Triton X-100 for 5 min on ice and fixed with 4% PFA for 20 min at RT. Coverslips were then washed twice in PBS, permeabilized with 0.1% Triton X-100 in PBS for 15 min at 4°C and blocked in 5% BSA 0.1% Triton X-100 in PBS overnight. Primary incubation was performed overnight in blocking solution using the anti-RAD51 antibody (Abcam; ab133534; 1:100). Coverslips were then washed with PBS containing 0.25% Tween 20. Secondary incubation was performed in PBS using Alexa 488 (1:500) for 1h at RT. Coverslips were then washed with PBS-T and stained with DAPI (1 μg/mL) and mounted on microscope slides with Fluoroshield (Sigma).</p></sec><sec id="S18"><title>Neutral Comet Assay</title><p id="P32">Neutral comet assays were performed using a Comet Assay kit from Amsbio (4250-050-K) according to the manufacturer’s protocol.</p></sec><sec id="S19"><title>Cell fractionation</title><p id="P33">1x106 U2OS cells were seeded. 24h later cells were treated for 24h with aph alone or in combination with checkpoint inhibitors (AZD-7662, 100nM) before harvesting for the indicated times. Cells were scraped in 1ml ice-cold PBS and spun down for 4 min at 500 g and resuspended in 200ul CSK buffer (10mM PIPES pH7.0, 100mM NaCl, 300mM Sucrose, 3 mM MgCL2, 1mM EGTA, 0.5% Triton, 1mM DTT and 1x of protease inhibitor mix (Complete, EDTA-free, Roche). Samples were incubated on ice for 10 min. Cells were spun down for 3 min at 1000 rpm. 150ul of supernatant, representing the soluble fraction, was collected and 50ul of 4x Laemmli Buffer (Bio-Rad) + 10% 2-metcaptoethanol (Sigma-Aldrich) was added. Residual soluble fraction was removed, and the chromatin pellet was washed in 500ul of CSK. 200uL of 1x Laemmli Buffer + 2.5% 2-metcaptoethanol was added. Samples were sonicated with a probe at medium intensity (10A) for 12 s in a Branson 250 instrument, and then incubated at 95°C for 10 min. 20ul of each sample was loaded and subjected to SDS-PAGE and immunoblotting.</p></sec></sec><sec sec-type="supplementary-material" id="SM"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><label>Tables S1 and S2</label><media xlink:href="EMS199838-supplement-Tables_S1_and_S2.xlsx" mimetype="application" mime-subtype="vnd.openxmlformats-officedocument.spreadsheetml.sheet" id="d20aAcEbB" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><label>Supplementary Figures</label><media xlink:href="EMS199838-supplement-Supplementary_Figures.pdf" mimetype="application" mime-subtype="pdf" id="d20aAcEcB" position="anchor"/></supplementary-material></sec></body><back><ack id="S20"><title>Acknowledgments</title><p>We thank Jiri Lukas for the gift of the SuperRPA cell line. We are grateful to the high throughput screening, light microscopy and flow cytometry science technology platforms at the Francis Crick Institute. We thank Allison McClure for stimulating discussions.</p><p>This work has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie (895786 to BC), Wellcome Trust Senior Investigator Awards (106252/Z/14/Z and 219527/Z/19/Z to JFXD), and a European Research Council Advanced Grant (669424-CHROMOREP to JFXD). This work was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001066), the UK Medical Research Council (FC001066), and the Wellcome Trust (FC001066). For the purpose of Open Access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission.</p></ack><fn-group><fn fn-type="con" id="FN2"><p id="P34"><bold>Author contributions</bold></p><p id="P35">Conceptualization: APB, BC, JFXD</p><p id="P36">Methodology: APB, BC, JFXD</p><p id="P37">Investigation: APB, BC, MY, JZ, RI,</p><p id="P38">MH Writing – original draft: APB, BC, JFXD</p><p id="P39">Writing – review &amp; editing: APB, BC, JFXD</p><p id="P40">Supervision: JFXD</p><p id="P41">Project administration: APB, BC, JFXD</p><p id="P42">Funding acquisition: BC, JFXD</p></fn><fn fn-type="conflict" id="FN3"><p id="P43"><bold>Declaration of interests</bold></p><p id="P44">The authors declare no competing interests.</p></fn></fn-group><ref-list><ref id="R1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saldivar</surname><given-names>JC</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><article-title>The essential kinase ATR: ensuring faithful duplication of a challenging genome</article-title><source>Nat Rev Mol Cell Biol</source><year>2017</year><volume>18</volume><fpage>622</fpage><lpage>636</lpage><pub-id pub-id-type="pmcid">PMC5796526</pub-id><pub-id pub-id-type="pmid">28811666</pub-id><pub-id pub-id-type="doi">10.1038/nrm.2017.67</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeman</surname><given-names>MK</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><article-title>Causes and consequences of replication stress</article-title><source>Nat Cell Biol</source><year>2014</year><volume>16</volume><fpage>2</fpage><lpage>9</lpage><pub-id pub-id-type="pmcid">PMC4354890</pub-id><pub-id pub-id-type="pmid">24366029</pub-id><pub-id pub-id-type="doi">10.1038/ncb2897</pub-id></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDougall</surname><given-names>CA</given-names></name><name><surname>Byun</surname><given-names>TS</given-names></name><name><surname>Van</surname><given-names>C</given-names></name><name><surname>Yee</surname><given-names>MC</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><article-title>The structural determinants of checkpoint activation</article-title><source>Genes Dev</source><year>2007</year><volume>21</volume><fpage>898</fpage><lpage>903</lpage><pub-id pub-id-type="pmcid">PMC1847708</pub-id><pub-id pub-id-type="pmid">17437996</pub-id><pub-id pub-id-type="doi">10.1101/gad.1522607</pub-id></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Fay</surname><given-names>DS</given-names></name><name><surname>Burton</surname><given-names>J</given-names></name><name><surname>Xiao</surname><given-names>H</given-names></name><name><surname>Pinkham</surname><given-names>JL</given-names></name><name><surname>Stern</surname><given-names>DF</given-names></name></person-group><article-title>SPK1 is an essential S-phase-specific gene of Saccharomyces cerevisiae that encodes a nuclear serine/threonine/tyrosine kinase</article-title><source>Mol Cell Biol</source><year>1993</year><volume>13</volume><fpage>5829</fpage><lpage>5842</lpage><pub-id pub-id-type="pmcid">PMC360328</pub-id><pub-id pub-id-type="pmid">8355715</pub-id><pub-id pub-id-type="doi">10.1128/mcb.13.9.5829</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weinert</surname><given-names>TA</given-names></name><name><surname>Kiser</surname><given-names>GL</given-names></name><name><surname>Hartwell</surname><given-names>LH</given-names></name></person-group><article-title>Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair</article-title><source>Genes Dev</source><year>1994</year><volume>8</volume><fpage>652</fpage><lpage>665</lpage><pub-id pub-id-type="pmid">7926756</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kato</surname><given-names>R</given-names></name><name><surname>Ogawa</surname><given-names>H</given-names></name></person-group><article-title>An essential gene, ESR1, is required for mitotic cell growth, DNA repair and meiotic recombination in Saccharomyces cerevisiae</article-title><source>Nucleic Acids Res</source><year>1994</year><volume>22</volume><fpage>3104</fpage><lpage>3112</lpage><pub-id pub-id-type="pmcid">PMC310282</pub-id><pub-id pub-id-type="pmid">8065923</pub-id><pub-id pub-id-type="doi">10.1093/nar/22.15.3104</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walworth</surname><given-names>N</given-names></name><name><surname>Davey</surname><given-names>S</given-names></name><name><surname>Beach</surname><given-names>D</given-names></name></person-group><article-title>Fission yeast chk1 protein kinase links the rad checkpoint pathway to cdc2</article-title><source>Nature</source><year>1993</year><volume>363</volume><fpage>368</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">8497322</pub-id></element-citation></ref><ref id="R8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Baltimore</surname><given-names>D</given-names></name></person-group><article-title>ATR disruption leads to chromosomal fragmentation and early embryonic lethality</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>397</fpage><lpage>402</lpage><pub-id pub-id-type="pmcid">PMC316378</pub-id><pub-id pub-id-type="pmid">10691732</pub-id></element-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Q</given-names></name><name><surname>Guntuku</surname><given-names>S</given-names></name><name><surname>Cui</surname><given-names>XS</given-names></name><name><surname>Matsuoka</surname><given-names>S</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name><name><surname>Tamai</surname><given-names>K</given-names></name><name><surname>Luo</surname><given-names>G</given-names></name><name><surname>Carattini-Rivera</surname><given-names>S</given-names></name><name><surname>DeMayo</surname><given-names>F</given-names></name><name><surname>Bradley</surname><given-names>A</given-names></name><etal/></person-group><article-title>Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint</article-title><source>Genes Dev</source><year>2000</year><volume>14</volume><fpage>1448</fpage><lpage>1459</lpage><pub-id pub-id-type="pmcid">PMC316686</pub-id><pub-id pub-id-type="pmid">10859164</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Chabes</surname><given-names>A</given-names></name><name><surname>Domkin</surname><given-names>V</given-names></name><name><surname>Thelander</surname><given-names>L</given-names></name><name><surname>Rothstein</surname><given-names>R</given-names></name></person-group><article-title>The ribonucleotide reductase inhibitor Sml1 is a new target of the Mec1/Rad53 kinase cascade during growth and in response to DNA damage</article-title><source>EMBO J</source><year>2001</year><volume>20</volume><fpage>3544</fpage><lpage>3553</lpage><pub-id pub-id-type="pmcid">PMC125510</pub-id><pub-id pub-id-type="pmid">11432841</pub-id><pub-id pub-id-type="doi">10.1093/emboj/20.13.3544</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortez</surname><given-names>D</given-names></name><name><surname>Guntuku</surname><given-names>S</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><article-title>ATR and ATRIP: partners in checkpoint signaling</article-title><source>Science</source><year>2001</year><volume>294</volume><fpage>1713</fpage><lpage>1716</lpage><pub-id pub-id-type="pmid">11721054</pub-id></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Klein</surname><given-names>A</given-names></name><name><surname>Muijtjens</surname><given-names>M</given-names></name><name><surname>van Os</surname><given-names>R</given-names></name><name><surname>Verhoeven</surname><given-names>Y</given-names></name><name><surname>Smit</surname><given-names>B</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name><name><surname>Lehmann</surname><given-names>AR</given-names></name><name><surname>Hoeijmakers</surname><given-names>JH</given-names></name></person-group><article-title>Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice</article-title><source>Curr Biol</source><year>2000</year><volume>10</volume><fpage>479</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">10801416</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name></person-group><article-title>The role of double-strand break repair - insights from human genetics</article-title><source>Nat Rev Genet</source><year>2006</year><volume>7</volume><fpage>45</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">16369571</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartkova</surname><given-names>J</given-names></name><name><surname>Horejsi</surname><given-names>Z</given-names></name><name><surname>Koed</surname><given-names>K</given-names></name><name><surname>Kramer</surname><given-names>A</given-names></name><name><surname>Tort</surname><given-names>F</given-names></name><name><surname>Zieger</surname><given-names>K</given-names></name><name><surname>Guldberg</surname><given-names>P</given-names></name><name><surname>Sehested</surname><given-names>M</given-names></name><name><surname>Nesland</surname><given-names>JM</given-names></name><name><surname>Lukas</surname><given-names>C</given-names></name><etal/></person-group><article-title>DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis</article-title><source>Nature</source><year>2005</year><volume>434</volume><fpage>864</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">15829956</pub-id></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gorgoulis</surname><given-names>VG</given-names></name><name><surname>Vassiliou</surname><given-names>LV</given-names></name><name><surname>Karakaidos</surname><given-names>P</given-names></name><name><surname>Zacharatos</surname><given-names>P</given-names></name><name><surname>Kotsinas</surname><given-names>A</given-names></name><name><surname>Liloglou</surname><given-names>T</given-names></name><name><surname>Venere</surname><given-names>M</given-names></name><name><surname>Ditullio</surname><given-names>RA</given-names></name><name><surname>Kastrinakis</surname><given-names>NG</given-names></name><name><surname>Levy</surname><given-names>B</given-names></name><etal/></person-group><article-title>Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions</article-title><source>Nature</source><year>2005</year><volume>434</volume><fpage>907</fpage><lpage>913</lpage><pub-id pub-id-type="pmid">15829965</pub-id></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murga</surname><given-names>M</given-names></name><name><surname>Bunting</surname><given-names>S</given-names></name><name><surname>Montana</surname><given-names>MF</given-names></name><name><surname>Soria</surname><given-names>R</given-names></name><name><surname>Mulero</surname><given-names>F</given-names></name><name><surname>Canamero</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>Y</given-names></name><name><surname>McKinnon</surname><given-names>PJ</given-names></name><name><surname>Nussenzweig</surname><given-names>A</given-names></name><name><surname>Fernandez-Capetillo</surname><given-names>O</given-names></name></person-group><article-title>A mouse model of ATR-Seckel shows embryonic replicative stress and accelerated aging</article-title><source>Nat Genet</source><year>2009</year><volume>41</volume><fpage>891</fpage><lpage>898</lpage><pub-id pub-id-type="pmcid">PMC2902278</pub-id><pub-id pub-id-type="pmid">19620979</pub-id><pub-id pub-id-type="doi">10.1038/ng.420</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name></person-group><article-title>Clinical impact of ATR checkpoint signalling failure in humans</article-title><source>Cell Cycle</source><year>2003</year><volume>2</volume><fpage>194</fpage><lpage>195</lpage><pub-id pub-id-type="pmid">12734423</pub-id></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Driscoll</surname><given-names>M</given-names></name><name><surname>Ruiz-Perez</surname><given-names>VL</given-names></name><name><surname>Woods</surname><given-names>CG</given-names></name><name><surname>Jeggo</surname><given-names>PA</given-names></name><name><surname>Goodship</surname><given-names>JA</given-names></name></person-group><article-title>A splicing mutation affecting expression of ataxia-telangiectasia and Rad3-related protein (ATR) results in Seckel syndrome</article-title><source>Nat Genet</source><year>2003</year><volume>33</volume><fpage>497</fpage><lpage>501</lpage><pub-id pub-id-type="pmid">12640452</pub-id></element-citation></ref><ref id="R19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zegerman</surname><given-names>P</given-names></name><name><surname>Diffley</surname><given-names>JF</given-names></name></person-group><article-title>DNA replication as a target of the DNA damage checkpoint</article-title><source>DNA Repair (Amst)</source><year>2009</year><volume>8</volume><fpage>1077</fpage><lpage>1088</lpage><pub-id pub-id-type="pmid">19505853</pub-id></element-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desany</surname><given-names>BA</given-names></name><name><surname>Alcasabas</surname><given-names>AA</given-names></name><name><surname>Bachant</surname><given-names>JB</given-names></name><name><surname>Elledge</surname><given-names>SJ</given-names></name></person-group><article-title>Recovery from DNA replicational stress is the essential function of the S-phase checkpoint pathway</article-title><source>Genes Dev</source><year>1998</year><volume>12</volume><fpage>2956</fpage><lpage>2970</lpage><pub-id pub-id-type="pmcid">PMC317167</pub-id><pub-id pub-id-type="pmid">9744871</pub-id><pub-id pub-id-type="doi">10.1101/gad.12.18.2956</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tercero</surname><given-names>JA</given-names></name><name><surname>Diffley</surname><given-names>JF</given-names></name></person-group><article-title>Regulation of DNA replication fork progression through damaged DNA by the Mec1/Rad53 checkpoint</article-title><source>Nature</source><year>2001</year><volume>412</volume><fpage>553</fpage><lpage>557</lpage><pub-id pub-id-type="pmid">11484057</pub-id></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segurado</surname><given-names>M</given-names></name><name><surname>Tercero</surname><given-names>JA</given-names></name></person-group><article-title>The S-phase checkpoint: targeting the replication fork</article-title><source>Biol Cell</source><year>2009</year><volume>101</volume><fpage>617</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">19686094</pub-id></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Mosqueda</surname><given-names>J</given-names></name><name><surname>Maas</surname><given-names>NL</given-names></name><name><surname>Jonsson</surname><given-names>ZO</given-names></name><name><surname>Defazio-Eli</surname><given-names>LG</given-names></name><name><surname>Wohlschlegel</surname><given-names>J</given-names></name><name><surname>Toczyski</surname><given-names>DP</given-names></name></person-group><article-title>Damage-induced phosphorylation of Sld3 is important to block late origin firing</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>479</fpage><lpage>483</lpage><pub-id pub-id-type="pmcid">PMC3393088</pub-id><pub-id pub-id-type="pmid">20865002</pub-id><pub-id pub-id-type="doi">10.1038/nature09377</pub-id></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zegerman</surname><given-names>P</given-names></name><name><surname>Diffley</surname><given-names>JF</given-names></name></person-group><article-title>Checkpoint-dependent inhibition of DNA replication initiation by Sld3 and Dbf4 phosphorylation</article-title><source>Nature</source><year>2010</year><volume>467</volume><fpage>474</fpage><lpage>478</lpage><pub-id pub-id-type="pmcid">PMC2948544</pub-id><pub-id pub-id-type="pmid">20835227</pub-id><pub-id pub-id-type="doi">10.1038/nature09373</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>C</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name></person-group><article-title>Checking on DNA damage in S phase</article-title><source>Nat Rev Mol Cell Biol</source><year>2004</year><volume>5</volume><fpage>792</fpage><lpage>804</lpage><pub-id pub-id-type="pmid">15459660</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mailand</surname><given-names>N</given-names></name><name><surname>Falck</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>C</given-names></name><name><surname>Syljuasen</surname><given-names>RG</given-names></name><name><surname>Welcker</surname><given-names>M</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name></person-group><article-title>Rapid destruction of human Cdc25A in response to DNA damage</article-title><source>Science</source><year>2000</year><volume>288</volume><fpage>1425</fpage><lpage>1429</lpage><pub-id pub-id-type="pmid">10827953</pub-id></element-citation></ref><ref id="R27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falck</surname><given-names>J</given-names></name><name><surname>Mailand</surname><given-names>N</given-names></name><name><surname>Syljuasen</surname><given-names>RG</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name></person-group><article-title>The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis</article-title><source>Nature</source><year>2001</year><volume>410</volume><fpage>842</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">11298456</pub-id></element-citation></ref><ref id="R28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><article-title>Preventing replication fork collapse to maintain genome integrity</article-title><source>DNA Repair (Amst)</source><year>2015</year><volume>32</volume><fpage>149</fpage><lpage>157</lpage><pub-id pub-id-type="pmcid">PMC4522347</pub-id><pub-id pub-id-type="pmid">25957489</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2015.04.026</pub-id></element-citation></ref><ref id="R29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tercero</surname><given-names>JA</given-names></name><name><surname>Longhese</surname><given-names>MP</given-names></name><name><surname>Diffley</surname><given-names>JF</given-names></name></person-group><article-title>A central role for DNA replication forks in checkpoint activation and response</article-title><source>Mol Cell</source><year>2003</year><volume>11</volume><fpage>1323</fpage><lpage>1336</lpage><pub-id pub-id-type="pmid">12769855</pub-id></element-citation></ref><ref id="R30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname><given-names>M</given-names></name><name><surname>Cotta-Ramusino</surname><given-names>C</given-names></name><name><surname>Pellicioli</surname><given-names>A</given-names></name><name><surname>Liberi</surname><given-names>G</given-names></name><name><surname>Plevani</surname><given-names>P</given-names></name><name><surname>Muzi-Falconi</surname><given-names>M</given-names></name><name><surname>Newlon</surname><given-names>CS</given-names></name><name><surname>Foiani</surname><given-names>M</given-names></name></person-group><article-title>The DNA replication checkpoint response stabilizes stalled replication forks</article-title><source>Nature</source><year>2001</year><volume>412</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="pmid">11484058</pub-id></element-citation></ref><ref id="R31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Piccoli</surname><given-names>G</given-names></name><name><surname>Katou</surname><given-names>Y</given-names></name><name><surname>Itoh</surname><given-names>T</given-names></name><name><surname>Nakato</surname><given-names>R</given-names></name><name><surname>Shirahige</surname><given-names>K</given-names></name><name><surname>Labib</surname><given-names>K</given-names></name></person-group><article-title>Replisome stability at defective DNA replication forks is independent of S phase checkpoint kinases</article-title><source>Mol Cell</source><year>2012</year><volume>45</volume><fpage>696</fpage><lpage>704</lpage><pub-id pub-id-type="pmid">22325992</pub-id></element-citation></ref><ref id="R32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>E</given-names></name><name><surname>Miyabe</surname><given-names>I</given-names></name><name><surname>Iraqui</surname><given-names>I</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Lambert</surname><given-names>SA</given-names></name><name><surname>Carr</surname><given-names>AM</given-names></name></person-group><article-title>The extent of error-prone replication restart by homologous recombination is controlled by Exo1 and checkpoint proteins</article-title><source>J Cell Sci</source><year>2014</year><volume>127</volume><fpage>2983</fpage><lpage>2994</lpage><pub-id pub-id-type="pmcid">PMC4075360</pub-id><pub-id pub-id-type="pmid">24806966</pub-id><pub-id pub-id-type="doi">10.1242/jcs.152678</pub-id></element-citation></ref><ref id="R33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cotta-Ramusino</surname><given-names>C</given-names></name><name><surname>Fachinetti</surname><given-names>D</given-names></name><name><surname>Lucca</surname><given-names>C</given-names></name><name><surname>Doksani</surname><given-names>Y</given-names></name><name><surname>Lopes</surname><given-names>M</given-names></name><name><surname>Sogo</surname><given-names>J</given-names></name><name><surname>Foiani</surname><given-names>M</given-names></name></person-group><article-title>Exo1 processes stalled replication forks and counteracts fork reversal in checkpoint-defective cells</article-title><source>Mol Cell</source><year>2005</year><volume>17</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">15629726</pub-id></element-citation></ref><ref id="R34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Segurado</surname><given-names>M</given-names></name><name><surname>Diffley</surname><given-names>JF</given-names></name></person-group><article-title>Separate roles for the DNA damage checkpoint protein kinases in stabilizing DNA replication forks</article-title><source>Genes Dev</source><year>2008</year><volume>22</volume><fpage>1816</fpage><lpage>1827</lpage><pub-id pub-id-type="pmcid">PMC2492668</pub-id><pub-id pub-id-type="pmid">18593882</pub-id><pub-id pub-id-type="doi">10.1101/gad.477208</pub-id></element-citation></ref><ref id="R35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oh</surname><given-names>J</given-names></name><name><surname>Symington</surname><given-names>LS</given-names></name></person-group><article-title>Role of the Mre11 Complex in Preserving Genome Integrity</article-title><source>Genes (Basel)</source><year>2018</year><volume>9</volume><pub-id pub-id-type="pmcid">PMC6315862</pub-id><pub-id pub-id-type="pmid">30501098</pub-id><pub-id pub-id-type="doi">10.3390/genes9120589</pub-id></element-citation></ref><ref id="R36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellicano</surname><given-names>G</given-names></name><name><surname>Al Mamun</surname><given-names>M</given-names></name><name><surname>Jurado-Santiago</surname><given-names>D</given-names></name><name><surname>Villa-Hernandez</surname><given-names>S</given-names></name><name><surname>Yin</surname><given-names>X</given-names></name><name><surname>Giannattasio</surname><given-names>M</given-names></name><name><surname>Lanz</surname><given-names>MC</given-names></name><name><surname>Smolka</surname><given-names>MB</given-names></name><name><surname>Yeeles</surname><given-names>J</given-names></name><name><surname>Shirahige</surname><given-names>K</given-names></name><etal/></person-group><article-title>Checkpoint-mediated DNA polymerase epsilon exonuclease activity curbing counteracts resection-driven fork collapse</article-title><source>Mol Cell</source><year>2021</year><volume>81</volume><fpage>2778</fpage><lpage>2792</lpage><elocation-id>e2774</elocation-id><pub-id pub-id-type="pmcid">PMC7612761</pub-id><pub-id pub-id-type="pmid">33932350</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2021.04.006</pub-id></element-citation></ref><ref id="R37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toledo</surname><given-names>LI</given-names></name><name><surname>Altmeyer</surname><given-names>M</given-names></name><name><surname>Rask</surname><given-names>MB</given-names></name><name><surname>Lukas</surname><given-names>C</given-names></name><name><surname>Larsen</surname><given-names>DH</given-names></name><name><surname>Povlsen</surname><given-names>LK</given-names></name><name><surname>Bekker-Jensen</surname><given-names>S</given-names></name><name><surname>Mailand</surname><given-names>N</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name></person-group><article-title>ATR prohibits replication catastrophe by preventing global exhaustion of RPA</article-title><source>Cell</source><year>2013</year><volume>155</volume><fpage>1088</fpage><lpage>1103</lpage><pub-id pub-id-type="pmid">24267891</pub-id></element-citation></ref><ref id="R38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Couch</surname><given-names>FB</given-names></name><name><surname>Bansbach</surname><given-names>CE</given-names></name><name><surname>Driscoll</surname><given-names>R</given-names></name><name><surname>Luzwick</surname><given-names>JW</given-names></name><name><surname>Glick</surname><given-names>GG</given-names></name><name><surname>Betous</surname><given-names>R</given-names></name><name><surname>Carroll</surname><given-names>CM</given-names></name><name><surname>Jung</surname><given-names>SY</given-names></name><name><surname>Qin</surname><given-names>J</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><article-title>ATR phosphorylates SMARCAL1 to prevent replication fork collapse</article-title><source>Genes Dev</source><year>2013</year><volume>27</volume><fpage>1610</fpage><lpage>1623</lpage><pub-id pub-id-type="pmcid">PMC3731549</pub-id><pub-id pub-id-type="pmid">23873943</pub-id><pub-id pub-id-type="doi">10.1101/gad.214080.113</pub-id></element-citation></ref><ref id="R39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syljuasen</surname><given-names>RG</given-names></name><name><surname>Sorensen</surname><given-names>CS</given-names></name><name><surname>Hansen</surname><given-names>LT</given-names></name><name><surname>Fugger</surname><given-names>K</given-names></name><name><surname>Lundin</surname><given-names>C</given-names></name><name><surname>Johansson</surname><given-names>F</given-names></name><name><surname>Helleday</surname><given-names>T</given-names></name><name><surname>Sehested</surname><given-names>M</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name><name><surname>Bartek</surname><given-names>J</given-names></name></person-group><article-title>Inhibition of human Chk1 causes increased initiation of DNA replication, phosphorylation of ATR targets, and DNA breakage</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>3553</fpage><lpage>3562</lpage><pub-id pub-id-type="pmcid">PMC1084285</pub-id><pub-id pub-id-type="pmid">15831461</pub-id><pub-id pub-id-type="doi">10.1128/MCB.25.9.3553-3562.2005</pub-id></element-citation></ref><ref id="R40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petermann</surname><given-names>E</given-names></name><name><surname>Maya-Mendoza</surname><given-names>A</given-names></name><name><surname>Zachos</surname><given-names>G</given-names></name><name><surname>Gillespie</surname><given-names>DA</given-names></name><name><surname>Jackson</surname><given-names>DA</given-names></name><name><surname>Caldecott</surname><given-names>KW</given-names></name></person-group><article-title>Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase</article-title><source>Mol Cell Biol</source><year>2006</year><volume>26</volume><fpage>3319</fpage><lpage>3326</lpage><pub-id pub-id-type="pmcid">PMC1446959</pub-id><pub-id pub-id-type="pmid">16581803</pub-id><pub-id pub-id-type="doi">10.1128/MCB.26.8.3319-3326.2006</pub-id></element-citation></ref><ref id="R41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menolfi</surname><given-names>D</given-names></name><name><surname>Lee</surname><given-names>BJ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Jiang</surname><given-names>W</given-names></name><name><surname>Bowen</surname><given-names>NE</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>J</given-names></name><name><surname>Holmes</surname><given-names>A</given-names></name><name><surname>Gershik</surname><given-names>S</given-names></name><name><surname>Rabadan</surname><given-names>R</given-names></name><etal/></person-group><article-title>ATR kinase supports normal proliferation in the early S phase by preventing replication resource exhaustion</article-title><source>Nat Commun</source><year>2023</year><volume>14</volume><elocation-id>3618</elocation-id><pub-id pub-id-type="pmcid">PMC10279696</pub-id><pub-id pub-id-type="pmid">37336885</pub-id><pub-id pub-id-type="doi">10.1038/s41467-023-39332-5</pub-id></element-citation></ref><ref id="R42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leung</surname><given-names>W</given-names></name><name><surname>Simoneau</surname><given-names>A</given-names></name><name><surname>Saxena</surname><given-names>S</given-names></name><name><surname>Jackson</surname><given-names>J</given-names></name><name><surname>Patel</surname><given-names>PS</given-names></name><name><surname>Limbu</surname><given-names>M</given-names></name><name><surname>Vindigni</surname><given-names>A</given-names></name><name><surname>Zou</surname><given-names>L</given-names></name></person-group><article-title>ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms</article-title><source>Cell Rep</source><year>2023</year><volume>42</volume><elocation-id>112792</elocation-id><pub-id pub-id-type="pmcid">PMC10529362</pub-id><pub-id pub-id-type="pmid">37454295</pub-id><pub-id pub-id-type="doi">10.1016/j.celrep.2023.112792</pub-id></element-citation></ref><ref id="R43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maya-Mendoza</surname><given-names>A</given-names></name><name><surname>Petermann</surname><given-names>E</given-names></name><name><surname>Gillespie</surname><given-names>DA</given-names></name><name><surname>Caldecott</surname><given-names>KW</given-names></name><name><surname>Jackson</surname><given-names>DA</given-names></name></person-group><article-title>Chk1 regulates the density of active replication origins during the vertebrate S phase</article-title><source>EMBO J</source><year>2007</year><volume>26</volume><fpage>2719</fpage><lpage>2731</lpage><pub-id pub-id-type="pmcid">PMC1888675</pub-id><pub-id pub-id-type="pmid">17491592</pub-id><pub-id pub-id-type="doi">10.1038/sj.emboj.7601714</pub-id></element-citation></ref><ref id="R44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petermann</surname><given-names>E</given-names></name><name><surname>Woodcock</surname><given-names>M</given-names></name><name><surname>Helleday</surname><given-names>T</given-names></name></person-group><article-title>Chk1 promotes replication fork progression by controlling replication initiation</article-title><source>Proc Natl Acad Sci U S A</source><year>2010</year><volume>107</volume><fpage>16090</fpage><lpage>16095</lpage><pub-id pub-id-type="pmcid">PMC2941317</pub-id><pub-id pub-id-type="pmid">20805465</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1005031107</pub-id></element-citation></ref><ref id="R45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petermann</surname><given-names>E</given-names></name><name><surname>Caldecott</surname><given-names>KW</given-names></name></person-group><article-title>Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase</article-title><source>Cell Cycle</source><year>2006</year><volume>5</volume><fpage>2203</fpage><lpage>2209</lpage><pub-id pub-id-type="pmid">16969104</pub-id></element-citation></ref><ref id="R46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costanzo</surname><given-names>V</given-names></name><name><surname>Shechter</surname><given-names>D</given-names></name><name><surname>Lupardus</surname><given-names>PJ</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name><name><surname>Gottesman</surname><given-names>M</given-names></name><name><surname>Gautier</surname><given-names>J</given-names></name></person-group><article-title>An ATR- and Cdc7-dependent DNA damage checkpoint that inhibits initiation of DNA replication</article-title><source>Mol Cell</source><year>2003</year><volume>11</volume><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">12535533</pub-id></element-citation></ref><ref id="R47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katsuno</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>A</given-names></name><name><surname>Sugimura</surname><given-names>K</given-names></name><name><surname>Okumura</surname><given-names>K</given-names></name><name><surname>Zineldeen</surname><given-names>DH</given-names></name><name><surname>Shimada</surname><given-names>M</given-names></name><name><surname>Niida</surname><given-names>H</given-names></name><name><surname>Mizuno</surname><given-names>T</given-names></name><name><surname>Hanaoka</surname><given-names>F</given-names></name><name><surname>Nakanishi</surname><given-names>M</given-names></name></person-group><article-title>Cyclin A-Cdk1 regulates the origin firing program in mammalian cells</article-title><source>Proc Natl Acad Sci U S A</source><year>2009</year><volume>106</volume><fpage>3184</fpage><lpage>3189</lpage><pub-id pub-id-type="pmcid">PMC2651338</pub-id><pub-id pub-id-type="pmid">19221029</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0809350106</pub-id></element-citation></ref><ref id="R48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shechter</surname><given-names>D</given-names></name><name><surname>Costanzo</surname><given-names>V</given-names></name><name><surname>Gautier</surname><given-names>J</given-names></name></person-group><article-title>ATR and ATM regulate the timing of DNA replication origin firing</article-title><source>Nat Cell Biol</source><year>2004</year><volume>6</volume><fpage>648</fpage><lpage>655</lpage><pub-id pub-id-type="pmid">15220931</pub-id></element-citation></ref><ref id="R49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schlacher</surname><given-names>K</given-names></name><name><surname>Christ</surname><given-names>N</given-names></name><name><surname>Siaud</surname><given-names>N</given-names></name><name><surname>Egashira</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Jasin</surname><given-names>M</given-names></name></person-group><article-title>Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11</article-title><source>Cell</source><year>2011</year><volume>145</volume><fpage>529</fpage><lpage>542</lpage><pub-id pub-id-type="pmcid">PMC3261725</pub-id><pub-id pub-id-type="pmid">21565612</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2011.03.041</pub-id></element-citation></ref><ref id="R50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elbaek</surname><given-names>CR</given-names></name><name><surname>Petrosius</surname><given-names>V</given-names></name><name><surname>Benada</surname><given-names>J</given-names></name><name><surname>Erichsen</surname><given-names>L</given-names></name><name><surname>Damgaard</surname><given-names>RB</given-names></name><name><surname>Sorensen</surname><given-names>CS</given-names></name></person-group><article-title>WEE1 kinase protects the stability of stalled DNA replication forks by limiting CDK2 activity</article-title><source>Cell Rep</source><year>2022</year><volume>38</volume><elocation-id>110261</elocation-id><pub-id pub-id-type="pmid">35045293</pub-id></element-citation></ref><ref id="R51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdel-Samad</surname><given-names>R</given-names></name><name><surname>Aouad</surname><given-names>P</given-names></name><name><surname>Gali-Muhtasib</surname><given-names>H</given-names></name><name><surname>Sweidan</surname><given-names>Z</given-names></name><name><surname>Hmadi</surname><given-names>R</given-names></name><name><surname>Kadara</surname><given-names>H</given-names></name><name><surname>D’Andrea</surname><given-names>EL</given-names></name><name><surname>Fucci</surname><given-names>A</given-names></name><name><surname>Pisano</surname><given-names>C</given-names></name><name><surname>Darwiche</surname><given-names>N</given-names></name></person-group><article-title>Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase alpha</article-title><source>Am J Cancer Res</source><year>2018</year><volume>8</volume><fpage>39</fpage><lpage>55</lpage><pub-id pub-id-type="pmcid">PMC5794720</pub-id><pub-id pub-id-type="pmid">29416919</pub-id></element-citation></ref><ref id="R52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ercilla</surname><given-names>A</given-names></name><name><surname>Benada</surname><given-names>J</given-names></name><name><surname>Amitash</surname><given-names>S</given-names></name><name><surname>Zonderland</surname><given-names>G</given-names></name><name><surname>Baldi</surname><given-names>G</given-names></name><name><surname>Somyajit</surname><given-names>K</given-names></name><name><surname>Ochs</surname><given-names>F</given-names></name><name><surname>Costanzo</surname><given-names>V</given-names></name><name><surname>Lukas</surname><given-names>J</given-names></name><name><surname>Toledo</surname><given-names>L</given-names></name></person-group><article-title>Physiological Tolerance to ssDNA Enables Strand Uncoupling during DNA Replication</article-title><source>Cell Rep</source><year>2020</year><volume>30</volume><fpage>2416</fpage><lpage>2429</lpage><elocation-id>e2417</elocation-id><pub-id pub-id-type="pmid">32075739</pub-id></element-citation></ref><ref id="R53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>T</given-names></name><name><surname>Goralski</surname><given-names>M</given-names></name><name><surname>Capota</surname><given-names>E</given-names></name><name><surname>Padrick</surname><given-names>SB</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Nijhawan</surname><given-names>D</given-names></name></person-group><article-title>The antitumor toxin CD437 is a direct inhibitor of DNA polymerase alpha</article-title><source>Nat Chem Biol</source><year>2016</year><volume>12</volume><fpage>511</fpage><lpage>515</lpage><pub-id pub-id-type="pmcid">PMC4912453</pub-id><pub-id pub-id-type="pmid">27182663</pub-id><pub-id pub-id-type="doi">10.1038/nchembio.2082</pub-id></element-citation></ref><ref id="R54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meroni</surname><given-names>A</given-names></name><name><surname>Wells</surname><given-names>SE</given-names></name><name><surname>Fonseca</surname><given-names>C</given-names></name><name><surname>Chaudhuri</surname><given-names>A Ray</given-names></name><name><surname>Caldecott</surname><given-names>KW</given-names></name><name><surname>Vindigni</surname><given-names>A</given-names></name></person-group><article-title>DNA combing versus DNA spreading and the separation of sister chromatids</article-title><source>J Cell Biol</source><year>2024</year><volume>223</volume><pub-id pub-id-type="pmcid">PMC10840220</pub-id><pub-id pub-id-type="pmid">38315097</pub-id><pub-id pub-id-type="doi">10.1083/jcb.202305082</pub-id></element-citation></ref><ref id="R55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paulsen</surname><given-names>RD</given-names></name><name><surname>Soni</surname><given-names>DV</given-names></name><name><surname>Wollman</surname><given-names>R</given-names></name><name><surname>Hahn</surname><given-names>AT</given-names></name><name><surname>Yee</surname><given-names>MC</given-names></name><name><surname>Guan</surname><given-names>A</given-names></name><name><surname>Hesley</surname><given-names>JA</given-names></name><name><surname>Miller</surname><given-names>SC</given-names></name><name><surname>Cromwell</surname><given-names>EF</given-names></name><name><surname>Solow-Cordero</surname><given-names>DE</given-names></name><etal/></person-group><article-title>A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability</article-title><source>Mol Cell</source><year>2009</year><volume>35</volume><fpage>228</fpage><lpage>239</lpage><pub-id pub-id-type="pmcid">PMC2772893</pub-id><pub-id pub-id-type="pmid">19647519</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2009.06.021</pub-id></element-citation></ref><ref id="R56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Aladjem</surname><given-names>MI</given-names></name><name><surname>Myung</surname><given-names>K</given-names></name></person-group><article-title>ATAD5 regulates the lifespan of DNA replication factories by modulating PCNA level on the chromatin</article-title><source>J Cell Biol</source><year>2013</year><volume>200</volume><fpage>31</fpage><lpage>44</lpage><pub-id pub-id-type="pmcid">PMC3542800</pub-id><pub-id pub-id-type="pmid">23277426</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201206084</pub-id></element-citation></ref><ref id="R57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubota</surname><given-names>T</given-names></name><name><surname>Nishimura</surname><given-names>K</given-names></name><name><surname>Kanemaki</surname><given-names>MT</given-names></name><name><surname>Donaldson</surname><given-names>AD</given-names></name></person-group><article-title>The Elg1 replication factor C-like complex functions in PCNA unloading during DNA replication</article-title><source>Mol Cell</source><year>2013</year><volume>50</volume><fpage>273</fpage><lpage>280</lpage><pub-id pub-id-type="pmid">23499004</pub-id></element-citation></ref><ref id="R58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olivieri</surname><given-names>M</given-names></name><name><surname>Cho</surname><given-names>T</given-names></name><name><surname>Alvarez-Quilon</surname><given-names>A</given-names></name><name><surname>Li</surname><given-names>K</given-names></name><name><surname>Schellenberg</surname><given-names>MJ</given-names></name><name><surname>Zimmermann</surname><given-names>M</given-names></name><name><surname>Hustedt</surname><given-names>N</given-names></name><name><surname>Rossi</surname><given-names>SE</given-names></name><name><surname>Adam</surname><given-names>S</given-names></name><name><surname>Melo</surname><given-names>H</given-names></name><etal/></person-group><article-title>A Genetic Map of the Response to DNA Damage in Human Cells</article-title><source>Cell</source><year>2020</year><volume>182</volume><fpage>481</fpage><lpage>496</lpage><elocation-id>e421</elocation-id><pub-id pub-id-type="pmcid">PMC7384976</pub-id><pub-id pub-id-type="pmid">32649862</pub-id><pub-id pub-id-type="doi">10.1016/j.cell.2020.05.040</pub-id></element-citation></ref><ref id="R59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname><given-names>S</given-names></name><name><surname>Mayor-Ruiz</surname><given-names>C</given-names></name><name><surname>Lafarga</surname><given-names>V</given-names></name><name><surname>Murga</surname><given-names>M</given-names></name><name><surname>Vega-Sendino</surname><given-names>M</given-names></name><name><surname>Ortega</surname><given-names>S</given-names></name><name><surname>Fernandez-Capetillo</surname><given-names>O</given-names></name></person-group><article-title>A Genome-wide CRISPR Screen Identifies CDC25A as a Determinant of Sensitivity to ATR Inhibitors</article-title><source>Mol Cell</source><year>2016</year><volume>62</volume><fpage>307</fpage><lpage>313</lpage><pub-id pub-id-type="pmcid">PMC5029544</pub-id><pub-id pub-id-type="pmid">27067599</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2016.03.006</pub-id></element-citation></ref><ref id="R60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lloyd</surname><given-names>RL</given-names></name><name><surname>Urban</surname><given-names>V</given-names></name><name><surname>Munoz-Martinez</surname><given-names>F</given-names></name><name><surname>Ayestaran</surname><given-names>I</given-names></name><name><surname>Thomas</surname><given-names>JC</given-names></name><name><surname>de Renty</surname><given-names>C</given-names></name><name><surname>O’Connor</surname><given-names>MJ</given-names></name><name><surname>Forment</surname><given-names>JV</given-names></name><name><surname>Galanty</surname><given-names>Y</given-names></name><name><surname>Jackson</surname><given-names>SP</given-names></name></person-group><article-title>Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>8665</fpage><lpage>8683</lpage><pub-id pub-id-type="pmcid">PMC8421211</pub-id><pub-id pub-id-type="pmid">34329458</pub-id><pub-id pub-id-type="doi">10.1093/nar/gkab628</pub-id></element-citation></ref><ref id="R61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>SH</given-names></name><name><surname>Kang</surname><given-names>N</given-names></name><name><surname>Song</surname><given-names>E</given-names></name><name><surname>Wie</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>EA</given-names></name><name><surname>Hwang</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Ra</surname><given-names>JS</given-names></name><name><surname>Park</surname><given-names>IB</given-names></name><name><surname>Park</surname><given-names>J</given-names></name><etal/></person-group><article-title>ATAD5 promotes replication restart by regulating RAD51 and PCNA in response to replication stress</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><elocation-id>5718</elocation-id><pub-id pub-id-type="pmcid">PMC6914801</pub-id><pub-id pub-id-type="pmid">31844045</pub-id><pub-id pub-id-type="doi">10.1038/s41467-019-13667-4</pub-id></element-citation></ref><ref id="R62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kulak</surname><given-names>NA</given-names></name><name><surname>Pichler</surname><given-names>G</given-names></name><name><surname>Paron</surname><given-names>I</given-names></name><name><surname>Nagaraj</surname><given-names>N</given-names></name><name><surname>Mann</surname><given-names>M</given-names></name></person-group><article-title>Minimal, encapsulated proteomic-sample processing applied to copy-number estimation in eukaryotic cells</article-title><source>Nat Methods</source><year>2014</year><volume>11</volume><fpage>319</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">24487582</pub-id></element-citation></ref><ref id="R63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kile</surname><given-names>AC</given-names></name><name><surname>Chavez</surname><given-names>DA</given-names></name><name><surname>Bacal</surname><given-names>J</given-names></name><name><surname>Eldirany</surname><given-names>S</given-names></name><name><surname>Korzhnev</surname><given-names>DM</given-names></name><name><surname>Bezsonova</surname><given-names>I</given-names></name><name><surname>Eichman</surname><given-names>BF</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><article-title>HLTF’s Ancient HIRAN Domain Binds 3’ DNA Ends to Drive Replication Fork Reversal</article-title><source>Mol Cell</source><year>2015</year><volume>58</volume><fpage>1090</fpage><lpage>1100</lpage><pub-id pub-id-type="pmcid">PMC4475461</pub-id><pub-id pub-id-type="pmid">26051180</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2015.05.013</pub-id></element-citation></ref><ref id="R64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>G</given-names></name><name><surname>Kermi</surname><given-names>C</given-names></name><name><surname>Stoy</surname><given-names>H</given-names></name><name><surname>Schiltz</surname><given-names>CJ</given-names></name><name><surname>Bacal</surname><given-names>J</given-names></name><name><surname>Zaino</surname><given-names>AM</given-names></name><name><surname>Hadden</surname><given-names>MK</given-names></name><name><surname>Eichman</surname><given-names>BF</given-names></name><name><surname>Lopes</surname><given-names>M</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><article-title>HLTF Promotes Fork Reversal, Limiting Replication Stress Resistance and Preventing Multiple Mechanisms of Unrestrained DNA Synthesis</article-title><source>Mol Cell</source><year>2020</year><volume>78</volume><fpage>1237</fpage><lpage>1251</lpage><elocation-id>e1237</elocation-id><pub-id pub-id-type="pmcid">PMC7305998</pub-id><pub-id pub-id-type="pmid">32442397</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2020.04.031</pub-id></element-citation></ref><ref id="R65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>G</given-names></name><name><surname>Endres</surname><given-names>T</given-names></name><name><surname>Kuhbacher</surname><given-names>U</given-names></name><name><surname>Mengoli</surname><given-names>V</given-names></name><name><surname>Greer</surname><given-names>BH</given-names></name><name><surname>Peacock</surname><given-names>EM</given-names></name><name><surname>Newton</surname><given-names>MD</given-names></name><name><surname>Stanage</surname><given-names>T</given-names></name><name><surname>Dello Stritto</surname><given-names>MR</given-names></name><name><surname>Lungu</surname><given-names>R</given-names></name><etal/></person-group><article-title>HLTF resolves G4s and promotes G4-induced replication fork slowing to maintain genome stability</article-title><source>Mol Cell</source><year>2024</year><volume>84</volume><fpage>3044</fpage><lpage>3060</lpage><elocation-id>e3011</elocation-id><pub-id pub-id-type="pmcid">PMC11366124</pub-id><pub-id pub-id-type="pmid">39142279</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2024.07.018</pub-id></element-citation></ref><ref id="R66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unk</surname><given-names>I</given-names></name><name><surname>Hajdu</surname><given-names>I</given-names></name><name><surname>Fatyol</surname><given-names>K</given-names></name><name><surname>Hurwitz</surname><given-names>J</given-names></name><name><surname>Yoon</surname><given-names>JH</given-names></name><name><surname>Prakash</surname><given-names>L</given-names></name><name><surname>Prakash</surname><given-names>S</given-names></name><name><surname>Haracska</surname><given-names>L</given-names></name></person-group><article-title>Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><fpage>3768</fpage><lpage>3773</lpage><pub-id pub-id-type="pmcid">PMC2268824</pub-id><pub-id pub-id-type="pmid">18316726</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0800563105</pub-id></element-citation></ref><ref id="R67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motegi</surname><given-names>A</given-names></name><name><surname>Liaw</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Roest</surname><given-names>HP</given-names></name><name><surname>Maas</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Moinova</surname><given-names>H</given-names></name><name><surname>Markowitz</surname><given-names>SD</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name><name><surname>Hoeijmakers</surname><given-names>JH</given-names></name><name><surname>Myung</surname><given-names>K</given-names></name></person-group><article-title>Polyubiquitination of proliferating cell nuclear antigen by HLTF and SHPRH prevents genomic instability from stalled replication forks</article-title><source>Proc Natl Acad Sci U S A</source><year>2008</year><volume>105</volume><fpage>12411</fpage><lpage>12416</lpage><pub-id pub-id-type="pmcid">PMC2518831</pub-id><pub-id pub-id-type="pmid">18719106</pub-id><pub-id pub-id-type="doi">10.1073/pnas.0805685105</pub-id></element-citation></ref><ref id="R68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Toorn</surname><given-names>M</given-names></name><name><surname>Turkyilmaz</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Kim</surname><given-names>HS</given-names></name><name><surname>Salas-Armenteros</surname><given-names>I</given-names></name><name><surname>Kim</surname><given-names>M</given-names></name><name><surname>Akita</surname><given-names>M</given-names></name><name><surname>Wienholz</surname><given-names>F</given-names></name><name><surname>Raams</surname><given-names>A</given-names></name><etal/></person-group><article-title>Active DNA damage eviction by HLTF stimulates nucleotide excision repair</article-title><source>Mol Cell</source><year>2022</year><volume>82</volume><fpage>1343</fpage><lpage>1358</lpage><elocation-id>e1348</elocation-id><pub-id pub-id-type="pmcid">PMC9473497</pub-id><pub-id pub-id-type="pmid">35271816</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2022.02.020</pub-id></element-citation></ref><ref id="R69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>D</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Colic</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Hart</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>CRISPR/CAS9-based DNA damage response screens reveal gene-drug interactions</article-title><source>DNA Repair (Amst)</source><year>2020</year><volume>87</volume><elocation-id>102803</elocation-id><pub-id pub-id-type="pmcid">PMC7034363</pub-id><pub-id pub-id-type="pmid">31991288</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2020.102803</pub-id></element-citation></ref><ref id="R70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>G</given-names></name><name><surname>Feng</surname><given-names>X</given-names></name><name><surname>Shepherd</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Srivastava</surname><given-names>M</given-names></name><name><surname>McLaughlin</surname><given-names>ME</given-names></name><name><surname>Navone</surname><given-names>NM</given-names></name><etal/></person-group><article-title>Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition</article-title><source>Oncogene</source><year>2019</year><volume>38</volume><fpage>2451</fpage><lpage>2463</lpage><pub-id pub-id-type="pmcid">PMC6450769</pub-id><pub-id pub-id-type="pmid">30532030</pub-id><pub-id pub-id-type="doi">10.1038/s41388-018-0606-4</pub-id></element-citation></ref><ref id="R71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unk</surname><given-names>I</given-names></name><name><surname>Hajdu</surname><given-names>I</given-names></name><name><surname>Blastyak</surname><given-names>A</given-names></name><name><surname>Haracska</surname><given-names>L</given-names></name></person-group><article-title>Role of yeast Rad5 and its human orthologs, HLTF and SHPRH in DNA damage tolerance</article-title><source>DNA Repair (Amst)</source><year>2010</year><volume>9</volume><fpage>257</fpage><lpage>267</lpage><pub-id pub-id-type="pmid">20096653</pub-id></element-citation></ref><ref id="R72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>DJ</given-names></name><name><surname>Cimprich</surname><given-names>KA</given-names></name></person-group><article-title>DNA damage tolerance: when it’s OK to make mistakes</article-title><source>Nat Chem Biol</source><year>2009</year><volume>5</volume><fpage>82</fpage><lpage>90</lpage><pub-id pub-id-type="pmcid">PMC2663399</pub-id><pub-id pub-id-type="pmid">19148176</pub-id><pub-id pub-id-type="doi">10.1038/nchembio.139</pub-id></element-citation></ref><ref id="R73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Motegi</surname><given-names>A</given-names></name><name><surname>Sood</surname><given-names>R</given-names></name><name><surname>Moinova</surname><given-names>H</given-names></name><name><surname>Markowitz</surname><given-names>SD</given-names></name><name><surname>Liu</surname><given-names>PP</given-names></name><name><surname>Myung</surname><given-names>K</given-names></name></person-group><article-title>Human SHPRH suppresses genomic instability through proliferating cell nuclear antigen polyubiquitination</article-title><source>J Cell Biol</source><year>2006</year><volume>175</volume><fpage>703</fpage><lpage>708</lpage><pub-id pub-id-type="pmcid">PMC2064669</pub-id><pub-id pub-id-type="pmid">17130289</pub-id><pub-id pub-id-type="doi">10.1083/jcb.200606145</pub-id></element-citation></ref><ref id="R74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neelsen</surname><given-names>KJ</given-names></name><name><surname>Lopes</surname><given-names>M</given-names></name></person-group><article-title>Replication fork reversal in eukaryotes: from dead end to dynamic response</article-title><source>Nat Rev Mol Cell Biol</source><year>2015</year><volume>16</volume><fpage>207</fpage><lpage>220</lpage><pub-id pub-id-type="pmid">25714681</pub-id></element-citation></ref><ref id="R75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolinjivadi</surname><given-names>AM</given-names></name><name><surname>Sannino</surname><given-names>V</given-names></name><name><surname>De Antoni</surname><given-names>A</given-names></name><name><surname>Zadorozhny</surname><given-names>K</given-names></name><name><surname>Kilkenny</surname><given-names>M</given-names></name><name><surname>Techer</surname><given-names>H</given-names></name><name><surname>Baldi</surname><given-names>G</given-names></name><name><surname>Shen</surname><given-names>R</given-names></name><name><surname>Ciccia</surname><given-names>A</given-names></name><name><surname>Pellegrini</surname><given-names>L</given-names></name><etal/></person-group><article-title>Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments</article-title><source>Mol Cell</source><year>2017</year><volume>67</volume><fpage>867</fpage><lpage>881</lpage><elocation-id>e867</elocation-id><pub-id pub-id-type="pmcid">PMC5594205</pub-id><pub-id pub-id-type="pmid">28757209</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2017.07.001</pub-id></element-citation></ref><ref id="R76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciccia</surname><given-names>A</given-names></name><name><surname>Nimonkar</surname><given-names>AV</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name><name><surname>Hajdu</surname><given-names>I</given-names></name><name><surname>Achar</surname><given-names>YJ</given-names></name><name><surname>Izhar</surname><given-names>L</given-names></name><name><surname>Petit</surname><given-names>SA</given-names></name><name><surname>Adamson</surname><given-names>B</given-names></name><name><surname>Yoon</surname><given-names>JC</given-names></name><name><surname>Kowalczykowski</surname><given-names>SC</given-names></name><etal/></person-group><article-title>Polyubiquitinated PCNA recruits the ZRANB3 translocase to maintain genomic integrity after replication stress</article-title><source>Mol Cell</source><year>2012</year><volume>47</volume><fpage>396</fpage><lpage>409</lpage><pub-id pub-id-type="pmcid">PMC3613862</pub-id><pub-id pub-id-type="pmid">22704558</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2012.05.024</pub-id></element-citation></ref><ref id="R77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vujanovic</surname><given-names>M</given-names></name><name><surname>Krietsch</surname><given-names>J</given-names></name><name><surname>Raso</surname><given-names>MC</given-names></name><name><surname>Terraneo</surname><given-names>N</given-names></name><name><surname>Zellweger</surname><given-names>R</given-names></name><name><surname>Schmid</surname><given-names>JA</given-names></name><name><surname>Taglialatela</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>JW</given-names></name><name><surname>Holland</surname><given-names>CL</given-names></name><name><surname>Zwicky</surname><given-names>K</given-names></name><etal/></person-group><article-title>Replication Fork Slowing and Reversal upon DNA Damage Require PCNA Polyubiquitination and ZRANB3 DNA Translocase Activity</article-title><source>Mol Cell</source><year>2017</year><volume>67</volume><fpage>882</fpage><lpage>890</lpage><elocation-id>e885</elocation-id><pub-id pub-id-type="pmcid">PMC5594246</pub-id><pub-id pub-id-type="pmid">28886337</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2017.08.010</pub-id></element-citation></ref><ref id="R78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joseph</surname><given-names>SA</given-names></name><name><surname>Taglialatela</surname><given-names>A</given-names></name><name><surname>Leuzzi</surname><given-names>G</given-names></name><name><surname>Huang</surname><given-names>JW</given-names></name><name><surname>Cuella-Martin</surname><given-names>R</given-names></name><name><surname>Ciccia</surname><given-names>A</given-names></name></person-group><article-title>Time for remodeling: SNF2-family DNA translocases in replication fork metabolism and human disease</article-title><source>DNA Repair (Amst)</source><year>2020</year><volume>95</volume><elocation-id>102943</elocation-id><pub-id pub-id-type="pmcid">PMC8092973</pub-id><pub-id pub-id-type="pmid">32971328</pub-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2020.102943</pub-id></element-citation></ref><ref id="R79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poole</surname><given-names>LA</given-names></name><name><surname>Cortez</surname><given-names>D</given-names></name></person-group><article-title>Functions of SMARCAL1, ZRANB3, and HLTF in maintaining genome stability</article-title><source>Crit Rev Biochem Mol Biol</source><year>2017</year><volume>52</volume><fpage>696</fpage><lpage>714</lpage><pub-id pub-id-type="pmcid">PMC5962345</pub-id><pub-id pub-id-type="pmid">28954549</pub-id><pub-id pub-id-type="doi">10.1080/10409238.2017.1380597</pub-id></element-citation></ref><ref id="R80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hishiki</surname><given-names>A</given-names></name><name><surname>Sato</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>H</given-names></name></person-group><article-title>Structure of HIRAN domain of human HLTF bound to duplex DNA provides structural basis for DNA unwinding to initiate replication fork regression</article-title><source>J Biochem</source><year>2020</year><volume>167</volume><fpage>597</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">31960921</pub-id></element-citation></ref><ref id="R81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinet</surname><given-names>A</given-names></name><name><surname>Tirman</surname><given-names>S</given-names></name><name><surname>Cybulla</surname><given-names>E</given-names></name><name><surname>Meroni</surname><given-names>A</given-names></name><name><surname>Vindigni</surname><given-names>A</given-names></name></person-group><article-title>To skip or not to skip: choosing repriming to tolerate DNA damage</article-title><source>Mol Cell</source><year>2021</year><volume>81</volume><fpage>649</fpage><lpage>658</lpage><pub-id pub-id-type="pmcid">PMC7935405</pub-id><pub-id pub-id-type="pmid">33515486</pub-id><pub-id pub-id-type="doi">10.1016/j.molcel.2021.01.012</pub-id></element-citation></ref><ref id="R82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClure</surname><given-names>AW</given-names></name><name><surname>Diffley</surname><given-names>JF</given-names></name></person-group><article-title>Rad53 checkpoint kinase regulation of DNA replication fork rate via Mrc1 phosphorylation</article-title><source>Elife</source><year>2021</year><volume>10</volume><pub-id pub-id-type="pmcid">PMC8387023</pub-id><pub-id pub-id-type="pmid">34387546</pub-id><pub-id pub-id-type="doi">10.7554/eLife.69726</pub-id></element-citation></ref><ref id="R83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lebrec</surname><given-names>V</given-names></name><name><surname>Poteau</surname><given-names>M</given-names></name><name><surname>Morretton</surname><given-names>JP</given-names></name><name><surname>Gavet</surname><given-names>O</given-names></name></person-group><article-title>Chk1 dynamics in G2 phase upon replication stress predict daughter cell outcome</article-title><source>Dev Cell</source><year>2022</year><volume>57</volume><fpage>638</fpage><lpage>653</lpage><elocation-id>e635</elocation-id><pub-id pub-id-type="pmid">35245445</pub-id></element-citation></ref><ref id="R84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moiseeva</surname><given-names>TN</given-names></name><name><surname>Yin</surname><given-names>Y</given-names></name><name><surname>Calderon</surname><given-names>MJ</given-names></name><name><surname>Qian</surname><given-names>C</given-names></name><name><surname>Schamus-Haynes</surname><given-names>S</given-names></name><name><surname>Sugitani</surname><given-names>N</given-names></name><name><surname>Osmanbeyoglu</surname><given-names>HU</given-names></name><name><surname>Rothenberg</surname><given-names>E</given-names></name><name><surname>Watkins</surname><given-names>SC</given-names></name><name><surname>Bakkenist</surname><given-names>CJ</given-names></name></person-group><article-title>An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication</article-title><source>Proc Natl Acad Sci U S A</source><year>2019</year><volume>116</volume><fpage>13374</fpage><lpage>13383</lpage><pub-id pub-id-type="pmcid">PMC6613105</pub-id><pub-id pub-id-type="pmid">31209037</pub-id><pub-id pub-id-type="doi">10.1073/pnas.1903418116</pub-id></element-citation></ref><ref id="R85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>Y</given-names></name><name><surname>Nellimoottil</surname><given-names>T</given-names></name><name><surname>Peace</surname><given-names>JM</given-names></name><name><surname>Knott</surname><given-names>SR</given-names></name><name><surname>Villwock</surname><given-names>SK</given-names></name><name><surname>Yee</surname><given-names>JM</given-names></name><name><surname>Jancuska</surname><given-names>JM</given-names></name><name><surname>Rege</surname><given-names>S</given-names></name><name><surname>Tecklenburg</surname><given-names>M</given-names></name><name><surname>Sclafani</surname><given-names>RA</given-names></name><etal/></person-group><article-title>The level of origin firing inversely affects the rate of replication fork progression</article-title><source>J Cell Biol</source><year>2013</year><volume>201</volume><fpage>373</fpage><lpage>383</lpage><pub-id pub-id-type="pmcid">PMC3639389</pub-id><pub-id pub-id-type="pmid">23629964</pub-id><pub-id pub-id-type="doi">10.1083/jcb.201208060</pub-id></element-citation></ref><ref id="R86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez-Acebes</surname><given-names>S</given-names></name><name><surname>Mouron</surname><given-names>S</given-names></name><name><surname>Mendez</surname><given-names>J</given-names></name></person-group><article-title>Uncoupling fork speed and origin activity to identify the primary cause of replicative stress phenotypes</article-title><source>J Biol Chem</source><year>2018</year><volume>293</volume><fpage>12855</fpage><lpage>12861</lpage><pub-id pub-id-type="pmcid">PMC6102153</pub-id><pub-id pub-id-type="pmid">29959228</pub-id><pub-id pub-id-type="doi">10.1074/jbc.RA118.003740</pub-id></element-citation></ref><ref id="R87"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandhu</surname><given-names>S</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Nabi</surname><given-names>Z</given-names></name><name><surname>Rastegar</surname><given-names>M</given-names></name><name><surname>Kung</surname><given-names>S</given-names></name><name><surname>Mai</surname><given-names>S</given-names></name><name><surname>Ding</surname><given-names>H</given-names></name></person-group><article-title>Loss of HLTF function promotes intestinal carcinogenesis</article-title><source>Mol Cancer</source><year>2012</year><volume>11</volume><fpage>18</fpage><pub-id pub-id-type="pmcid">PMC3337324</pub-id><pub-id pub-id-type="pmid">22452792</pub-id><pub-id pub-id-type="doi">10.1186/1476-4598-11-18</pub-id></element-citation></ref><ref id="R88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naryzhny</surname><given-names>SN</given-names></name><name><surname>Lee</surname><given-names>H</given-names></name></person-group><article-title>Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA</article-title><source>FEBS Lett</source><year>2007</year><volume>581</volume><fpage>4917</fpage><lpage>4920</lpage><pub-id pub-id-type="pmid">17900571</pub-id></element-citation></ref><ref id="R89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Xiao</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>T</given-names></name></person-group><article-title>Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma</article-title><source>Aging (Albany NY)</source><year>2022</year><volume>14</volume><fpage>3705</fpage><lpage>3719</lpage><pub-id pub-id-type="pmcid">PMC9085243</pub-id><pub-id pub-id-type="pmid">35483337</pub-id><pub-id pub-id-type="doi">10.18632/aging.204039</pub-id></element-citation></ref><ref id="R90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Gan</surname><given-names>S</given-names></name><name><surname>Ren</surname><given-names>L</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Qi</surname><given-names>X</given-names></name></person-group><article-title>Multifaceted regulation and functions of replication factor C family in human cancers</article-title><source>Am J Cancer Res</source><year>2018</year><volume>8</volume><fpage>1343</fpage><lpage>1355</lpage><pub-id pub-id-type="pmcid">PMC6129478</pub-id><pub-id pub-id-type="pmid">30210909</pub-id></element-citation></ref><ref id="R91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bell</surname><given-names>DW</given-names></name><name><surname>Sikdar</surname><given-names>N</given-names></name><name><surname>Lee</surname><given-names>KY</given-names></name><name><surname>Price</surname><given-names>JC</given-names></name><name><surname>Chatterjee</surname><given-names>R</given-names></name><name><surname>Park</surname><given-names>HD</given-names></name><name><surname>Fox</surname><given-names>J</given-names></name><name><surname>Ishiai</surname><given-names>M</given-names></name><name><surname>Rudd</surname><given-names>ML</given-names></name><name><surname>Pollock</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Predisposition to cancer caused by genetic and functional defects of mammalian Atad5</article-title><source>PLoS Genet</source><year>2011</year><volume>7</volume><elocation-id>e1002245</elocation-id><pub-id pub-id-type="pmcid">PMC3161924</pub-id><pub-id pub-id-type="pmid">21901109</pub-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1002245</pub-id></element-citation></ref><ref id="R92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kostovska</surname><given-names>I Maleva</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Bogdanova</surname><given-names>N</given-names></name><name><surname>Schurmann</surname><given-names>P</given-names></name><name><surname>Bhuju</surname><given-names>S</given-names></name><name><surname>Geffers</surname><given-names>R</given-names></name><name><surname>Durst</surname><given-names>M</given-names></name><name><surname>Liebrich</surname><given-names>C</given-names></name><name><surname>Klapdor</surname><given-names>R</given-names></name><name><surname>Christiansen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Rare ATAD5 missense variants in breast and ovarian cancer patients</article-title><source>Cancer Lett</source><year>2016</year><volume>376</volume><fpage>173</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">27045477</pub-id></element-citation></ref><ref id="R93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michailidou</surname><given-names>K</given-names></name><name><surname>Beesley</surname><given-names>J</given-names></name><name><surname>Lindstrom</surname><given-names>S</given-names></name><name><surname>Canisius</surname><given-names>S</given-names></name><name><surname>Dennis</surname><given-names>J</given-names></name><name><surname>Lush</surname><given-names>MJ</given-names></name><name><surname>Maranian</surname><given-names>MJ</given-names></name><name><surname>Bolla</surname><given-names>MK</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Shah</surname><given-names>M</given-names></name><etal/></person-group><article-title>Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer</article-title><source>Nat Genet</source><year>2015</year><volume>47</volume><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="pmcid">PMC4549775</pub-id><pub-id pub-id-type="pmid">25751625</pub-id><pub-id pub-id-type="doi">10.1038/ng.3242</pub-id></element-citation></ref><ref id="R94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuchenbaecker</surname><given-names>KB</given-names></name><name><surname>Ramus</surname><given-names>SJ</given-names></name><name><surname>Tyrer</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Shen</surname><given-names>HC</given-names></name><name><surname>Beesley</surname><given-names>J</given-names></name><name><surname>Lawrenson</surname><given-names>K</given-names></name><name><surname>McGuffog</surname><given-names>L</given-names></name><name><surname>Healey</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>JM</given-names></name><etal/></person-group><article-title>Identification of six new susceptibility loci for invasive epithelial ovarian cancer</article-title><source>Nat Genet</source><year>2015</year><volume>47</volume><fpage>164</fpage><lpage>171</lpage><pub-id pub-id-type="pmcid">PMC4445140</pub-id><pub-id pub-id-type="pmid">25581431</pub-id><pub-id pub-id-type="doi">10.1038/ng.3185</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><title>Checkpoint inhibition after replication fork stalling induces S phase catastrophe.</title><p><bold>(A)</bold> Survival assay of U2OS cells treated with indicated doses of Chk1i (AZD7762) in combination with aphidicolin. Viability was determined using CellTiter-Glo and normalised to aph-untreated cells. <bold>(B)</bold> S phase progression analysis. 0, 8 and 16h after release in media with 100 nM taxol. <bold>(C)</bold> Mitotic entry analysis. 16h after release in media with 100 nM taxol. The proportion of pH3-S10 positive cells is shown. <bold>(D)</bold> DNA fiber analysis of individual replication fork progression. Upper panel, experimental setup: cells were pulsed with CldU for 20 min, washed and incubated with IdU and aph alone or in combination with Chk1i for 4h. Cells were then washed and incubated again only with IdU for 20-, 40-, 60-and 120-min. Bottom panel, representative micrographs of CldU-IdU replication tracks. <bold>(E-F)</bold> Scatter plot and mean IdU track length in bicolour fibers (<bold>E</bold>) or red-only fibers (<bold>F</bold>). <bold>(G)</bold> DNA fiber analysis of Polα-dependent synthesis following checkpoint inhibition. Experimental setup as in <bold>D</bold> but the Polα inhibitor ST1926 (4 μM) was added during release. Scatter plot and mean IdU track length in bicolour fibers. <bold>(H)</bold> Average length increase for IdU tracks of bicolour fibers during <bold>release</bold>.</p></caption><graphic xlink:href="EMS199838-f001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><title>Order of effects following checkpoint inhibition.</title><p><bold>(A-B)</bold> Flow cytometry analysis of DNA damage markers as depicted in <xref ref-type="supplementary-material" rid="SD1">Figure S2A</xref>. <bold>(A)</bold> Percentage of cells presenting high γH2AX and phospho-S824 KAP1 levels in cells treated with aph alone or in combination with Chk1i. <bold>(B)</bold> Levels of chromatin-bound RPA32 and γH2AX in the same population of cells. Representative images comparing γH2AX intensity (log scale) and chromatin-bound RPA32 intensity (log scale) in cells. Gated cells depicted in red represent cells with simultaneously high levels of γH2AX and RPA. Bottom right of each panel, percentage of red coloured cells. <bold>(C-E)</bold> DNA fiber analysis of replication fork progression and origin firing. <bold>(C)</bold> Experimental setup: cells were pulsed with CldU for 20 min, washed and then incubated with IdU plus 1 μg/ml aph alone or in combination with 50 nM Chk1i for the indicated time. Cells were then washed and released in complete media containing IdU for 40 min. <bold>(D)</bold> Percentage of new origins fired was determined by counting the number of IdU-only tracts over the total number of different replication structures. <bold>(E)</bold> Scatter plot and mean IdU track length in bicolour fibers.</p></caption><graphic xlink:href="EMS199838-f002"/></fig><fig id="F3" position="float"><label>Figure 3</label><caption><title>Excess origin firing depletes chromatin-bound PCNA and causes replication fork defects.</title><p><bold>(A-C)</bold> Cells were treated with aph alone or in combination with Chk1i with and without Cdc7i (XL-143) or CDK2i (roscovitine). <bold>(A)</bold> Percentage of new origins fired. <bold>(B)</bold> DNA damage markers immunoblots. <bold>(C)</bold> Scatter plot and mean IdU track length in bicolour fibers. <bold>(D)</bold> Survival assay of cells treated with indicated concentrations of Chk1i alone or in combination with roscovitine. <bold>(E-F)</bold> Chromatin-bound RPA32 and RPA70 (<bold>E</bold>) and PCNA (<bold>F</bold>) in aph/Chk1i-treated cells. Graphs show fold change of mean fluorescence intensities (MFI) in comparison with aph alone. <bold>(G)</bold> Replication fork progression by DNA fiber analysis in aph-treated cells depleted for PCNA and RFC1 alone or in combination. Scatter plot and mean IdU track length in bicolour fibers. <bold>(H)</bold> Percentage of cells presenting high levels of γH2AX in aph-treated cells depleted for PCNA and RFC1 alone or in combination. <bold>(I)</bold> Immunoblot of chromatin extracts of aphidicolin treated cells for 24h alone or with the addition of 50 nM Chk1 inhibitor during the indicated times just before harvesting. Histone 3 (H3) was used as a loading control for chromatin fraction. <bold>(J)</bold> MFI of chromatin-bound PCNA in ATAD5 depleted cells. <bold>(K)</bold> DNA fiber analysis of replication fork progression in ATAD5 depleted cells. Left, scatter plot and mean IdU track length in bicolour fibers. Right, representative micrographs. <bold>(L)</bold> Percentage of control or ATAD5 depleted cells presenting high levels of γH2AX. <bold>(M)</bold> Percentage of new origins fired in control and ATAD5 depleted cells.</p></caption><graphic xlink:href="EMS199838-f003"/></fig><fig id="F4" position="float"><label>Figure 4</label><caption><title>HLTF is responsible for the defects caused by RFC/PCNA-depleted forks in the absence of the checkpoint.</title><p><bold>(A)</bold> Immunoblots for DNA damage markers in control, HLTF siRNA knock-down (KD) and HLTF CRISPR knock-out (KO) cells after checkpoint inhibition. <bold>(B)</bold> Flow cytometry analysis of chromatin-bound RPA32 and γH2AX levels in the same population of cells. Gated cells depicted in red represent cells with simultaneously high levels of γH2AX and RPA. Bottom right of each panel, percentage of red coloured cells. <bold>(C)</bold> Mitotic entry analysis. Cells were treated with aph for 24h, with or without Chk1i during the final 4 hours. Cells were washed and released for 16h. The proportion of pH3-S10 positive cells is shown. <bold>(D, E)</bold> Kinetic analysis of replication fork progression and origin firing in checkpoint inhibited conditions by DNA fiber. <bold>(D)</bold> Upper panel, experimental setup. Bottom panel, representative micrographs. <bold>(E)</bold> Scatter plot and mean IdU track length in bicolour fibers. <bold>(F, G)</bold> Survival assay of HLTF-KO or KD cells treated with indicated concentrations of Chk1i (AZD7762, MK-8776) or ATRi (VE-822) alone (<bold>F</bold>) or in combination with aph (<bold>G</bold>).</p></caption><graphic xlink:href="EMS199838-f004"/></fig><fig id="F5" position="float"><label>Figure 5</label><caption><title>HLTF is responsible for the defects caused by RFC/PCNA-depleted forks</title><p><bold>(A)</bold> Flow cytometry analysis of the percentage of aph-treated cells presenting high levels of γH2AX chromatin staining in control cells and PCNA siRNA treated cells alone or in combination with HLTF or ATAD5 siRNA. <bold>(B)</bold> DNA fiber analysis of replication fork progression in aph conditions in control cells and PCNA siRNA treated cells alone or in combination with HLTF or ATAD5 siRNA. Cells were pulsed with CldU for 20 min, washed and then incubated with IdU plus 1 μg/ml aph for 4h. Cells were then washed and incubated again only with IdU for 40 min. Scatter plot and mean IdU track length in bicolour fibers. At least 120 forks were scored per sample. <bold>(C)</bold> Flow cytometry analysis of the percentage of cells presenting high levels of pKAP1 staining. Control cells were treated with 1 μg/ml aph for 24h alone. Control cells and cells treated with PCNA or RFC1 siRNA alone or in combination with HLTF siRNA were subjected to aph for 24h and a checkpoint inhibitor with or without a CDK2i (roscovitine, 5 μM) was added during the final 4 hrs. <bold>(D)</bold> Flow cytometry analysis of the percentage of tetON-HLTF wild type U2OS cells presenting high levels of DNA damage markers (γH2AX and pRPA-S33) after treatment with aph alone or in combination with Chk11i with or without Cdc7i (XL-143, 10 μM). <bold>(E)</bold> Proposed order of events and dependencies during replication fork collapse in the absence of a functional checkpoint. <bold>(F)</bold> Model for coordination of fork progression and origin firing via checkpoint activation and dNTP/RFC/PCNA depletion.</p></caption><graphic xlink:href="EMS199838-f005"/></fig></floats-group></article>